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Despite the high degree of similarity between the human and chimpanzee genomes 
(98.5%), a number of phenotypic traits distinguish the two species. Some of these traits 
include a larger brain, with certain areas of specialized function, and a higher incidence 
of cancer in humans. One pathway that is common to both brain development and disease 
progression to cancer is apoptosis.  
 
During neuronal development, apoptosis functions by controlling the number of cells. In 
cancer, however, the ability of the apoptotic pathway to limit uncontrolled cell growth is 
lost. This research aims at exploring whether there is a difference in the apoptotic 
turnover between the two species. If so, this difference may explain differences in the 
above phenotypic traits. This research also explores the genetic basis of the some of the 
phenotypic differences between the two species. 
 
Microarray analysis, pathway prediction analysis, high throughput genome processing, 
statistical analysis, data management and experimental evidence were all used to achieve 
two major research advances in the comparison of humans and chimpanzees with respect 
to apoptotic function and in the understanding of the genetic basis of the phenotypic 
differences between the two species. 
 
 Research Advance 1: Gene expression analysis and pathway analysis were used to 
identify pathways that were enriched with genes that were differentially expressed 
between humans and chimpanzees. Based on these analyses, it was predicted that the 
 xviii 
apoptotic pathway has a reduced function in humans compared to chimpanzees. Tests 
were then carried out on human, chimpanzee and macaque cell lines to compare the 
apoptotic turnover among these species. Comparing results from the tests showed that 
apoptosis has a reduced turnover in humans, compared to both chimpanzee and 
macaques. This reduced turnover may account for the larger size of the human brain (due 
to apoptotic turnover being reduced during development) and an increased susceptibility 
to cancer in humans (due to apoptosis being suppressed during cancer). 
 
Research Advance 2: Microarray analysis, statistical analysis and high throughput 
genome processing was used to identify and associate INDEL variation (80-12,000 bp) 
with differential gene expression between humans and chimpanzees. A significant 
association was found between differential gene expression and INDEL variation 
between humans and chimpanzees, primarily involving the insertion of interspersed 
(predominantly retrotransposon) and non-interspersed sequences in the human lineage. 
The majority of this functionally significant INDEL variation was mapped to the introns 




INTRODUCTION AND LITERATURE SURVEY 
 
Humans (Homo sapiens) differ from their closest primate relatives in a number of 
characteristics. Some of the characteristics that are human-specific include bipedalism, an 
exceptionally large brain, use of complex language and other unusual cognitive and 
behavioral abilities (Gagneux and Varki 2001; Hacia 2001; Carroll 2003; de Sousa and 
Wood 2007; Varki 2007). The disease profile of humans differs from that of other 
primates, e.g. humans are vulnerable to neurodegenerative diseases like Huntington’s and 
Alzheimer’s (Gearing et al. 1994; Poduri et al. 1994; Walker 1999). Additionally, 
humans not only show a progression from HIV to AIDS (Rutjens et al. 2003), but also 
show a higher susceptibility to certain cancers (McClure 1973). The high susceptibility to 
neurodegenerative diseases and cancer in humans may be linked to the fact that among all 
the primates, humans have the longest lifespan (Hawkes et al. 1998; Blurton Jones et al. 
2002). 
 
Much before the era of modern biology, Huxley (Huxley 1863) and Darwin (Darwin 
1871) postulated that among the primates, the African great apes, i.e. chimpanzees (Pan 
troglodytes) and gorillas (Gorilla gorilla), are the closest relatives of the humans. DNA 
sequence analysis and cytogenetic studies have since shown that the genomes of humans 
are strikingly similar to the genomes of the African great apes (Sibley and Ahlquist 1987; 
Caccone and Powell 1989). Independent studies done on chimpanzees have shown that 
they also engage in cultural practices (Whiten et al. 1999), use tools (Biro et al. 2003; 
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Yamakoshi and Myowa-Yamakoshi 2004) and display rudimentary forms of language 
(Savage-Rumbaugh et al. 1978; Savage-Rumbaugh et al. 1985; Bodamer and Gardner 
2002). It has been proposed that focusing on the differences between the genomes of 
humans and the African great apes would provide a better understanding of the genetic 
basis for distinctly human traits (Varki 2000; Gagneux and Varki 2001). 
 
This chapter explores the known genetic differences between humans and African great 
apes, especially the chimpanzees. A major gap in the previous studies is the lack of data 
on the differences between humans and chimpanzees in pathway function. Pathways like 
apoptosis are important during development of human specific characteristics like a 
bigger brain and the susceptibility of humans to diseases like cancer. This chapter 
reviews the mechanism of apoptosis in detail and explores its role in the known 
phenotypic differences between humans and chimpanzees.  Later on in the chapter, the 
potential role of insertion/deletion (INDELs) events to the phenotypic differences 
between humans and chimpanzees is explored. 
 
Among the African great apes, the chimpanzees are the closest relatives of the 
humans 
The first studies (Sibley and Ahlquist 1987; Caccone and Powell 1989) comparing the 
large-scale DNA sequences between human and African great ape genomes reported 
estimates of divergence dates between humans and chimpanzee lineages as 5.8-7.1 
million years ago (MYA)  and between human and gorilla lineages as 8.3-10.1 MYA. 
These studies used hybridization melting curve analysis of non-repetitive human and 
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great ape DNA sequences and showed that the human and chimpanzee non-repetitive 
DNA sequence had more closely related melting points than the human and gorilla 
sequences.  
 
A number of comparative studies done on a large number of human, chimpanzee and 
gorilla sequenced loci, as well as one phylogenetic study (Figure 1.1) (Goodman 1996), 
support the human-chimpanzee dichotomy  (Ruvolo 1997; Chen and Li 2001; Kaessmann 
et al. 2001) rather than a human-chimpanzee-gorilla trichotomy (Satta et al. 2000). The 
main goal of one of these comparative sequence studies (Chen and Li 2001) was to 
determine the sequence similarities between the human, chimpanzee and gorilla genomes. 
Sequence comparisons were done on randomly distributed 24 kb intergenic non-repetitive 
sequences, and it was shown that the human sequences were 98.67% similar to the 
chimpanzee sequences and 98.38% similar to the gorilla sequences. In this study (Chen 
and Li 2001 ), it was also shown that the common ancestor of the human and 
chimpanzees existed 4.6-6.2 MYA, and that the common ancestor of the humans and 





Figure 1.1: Phylogenetic comparisons of primate species. Scale at the bottom shows 




Independent fossil data suggest that the last common ancestor of humans within the 
chimpanzee-bonobo clade lived approximately 6-7 MYA (Brunet et al. 2002). The fossil 
record, however, consists predominantly of fossils of human ancestors and related species 
and has provided extensive data regarding the evolution of human ancestors (Wood and 
Collard 1999). In the case of the chimpanzee lineage, only one known example of a 





Initial studies comparing humans and chimpanzees found very few genetic 
differences between the two species 
Once it was established that the closest relatives of the humans were the chimpanzees, the 
genetic differences between the two species were explored. While the biochemical 
similarities between humans and chimpanzees have been noted for nearly a century, most 
of this evidence was based on immunological studies (Nutall 1904). In the second half of 
the twentieth century, comparative studies between humans and chimpanzees were done 
by electrophoretic analysis of blood proteins and by protein sequencing (Syner and 
Goodman 1966; Sarich and Wilson 1967; Doolittle et al. 1971; King and Wilson 1975). 
These studies helped us understand the genetic differences between the two species. 
 
Initial studies comparing humans and chimpanzees sequences found very few differences 
between the two species 
In a classic study (King and Wilson 1975) done in 1975, comparing the protein sequences 
of humans and chimpanzees, Mary-Claire King and Allan Wilson concluded that the 
humans and chimpanzees are 99% identical at the protein level and that the small degree 
of sequence divergence between the two species may not be sufficient to account for the 
phenotypic differences between the two species. They proposed that differences in gene 
regulation might be responsible for the phenotypic differences. Following this study, a 
number of follow-up studies (Doolittle et al. 1971; Eyre-Walker and Keightley 1999; 
Fujiyama et al. 2002) confirmed that the differences in amino-acid sequences between the 
two species is <1%.  
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Studies done by comparing direct samplings of chimpanzee genomic DNA with 
corresponding segments of the human genome (Britten 2002) indicate that 95% of the 
chimpanzee genome can be directly aligned with the human genome and that the 
sequence divergence in these precisely aligned regions is 1-2%  (Fujiyama et al. 2002). 
The 5% divergence is due to insertions or deletions that have occurred in either genome 
since the divergence from the last common ancestor. 
 
Other approaches found very few genetic differences between humans and chimpanzees 
Other studies using different approaches have also reported very few genetic differences 
between humans and chimpanzees. The first genetic differences that became directly 
observable were the chromosomal differences between the two species, as highlighted by 
the karyotyping studies using a variety of dyes and fluorescent in situ hybridization 
(Yunis et al. 1980). The human-specific changes include a telomeric fusion of two 
ancestral chromosomes to form human chromosome 2 (chimpanzee chromosome 12 and 
13) (Yunis et al. 1980); pericentric inversions of chromosome 1 and 18; and 
redistribution of heterochromatin on several chromosomes  (Yunis et al. 1980; Yunis and 
Prakash 1982; Archidiacono et al. 1995; Meneveri et al. 1995).  
 
An alternative to the King and Wilson gene regulation hypothesis (King and Wilson 
1975) is the ‘less-is-more-hypothesis’, which emphasizes the loss of function of certain 
genes through gene inactivation events (Olson and Varki 2003). These inactivation events 
may have led to the evolution of a novel lineage such as the humans. A number of studies 
were done to identify gene inactivation events in both species. One such study reported 
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that unlike the chimpanzees, humans could not synthesize a form of cell surface sialic 
acid called N-glcolyl-neuraminic acid (Neu5Gc) (Chou et al. 1998). This sialic acid is 
widely expressed on the cell surfaces in many tissues in non-human primates. The 
synthesis of Neu5Gc depends on the hydroxylation of the precursor protein N-
acetylneuraminic acid by CMP-Neu5Ac hydroxylase. In humans, the hydroxylase has 
been inactivated by a 92 bp deletion. This inactivation in humans could help explain the 
immunity that humans have to certain infections caused by viral and bacterial organisms 
that require Neu5Gc to recognize gut epithelial cells (Karlsson 1995; Varki 1997). Other 
known gene inactivation events in the human lineage involve the loss of one member of a 
large gene family, the members of which share overlapping functions. These gene 
inactivation events include the V10 variable gene of the human T-cell-receptor-% locus 
(Zhang et al. 1996; Rouquier et al. 1998), the olfactory receptor gene OR 912-93 
(Rouquier et al. 1998) and a type I hair-keratin gene (Winter et al. 2001).  
 
Traditional ideas about genetic changes that lead to the evolution of new biological 
characteristics emphasize the role of gene duplication and divergence (Samonte and 
Eichler 2002). An example of a gene duplication event that is specific to humans is the 
gene that encodes protocadherin XY (Wu 2005). This gene lies in a region of the human 
Y chromosome that was duplicated and translocated from the X chromosome, after the 
last common ancestor of humans and chimpanzees. It has been postulated that 
protocadherin XY is involved in handedness, language lateralization and brain 
asymmetry (Crow 2002). This example of protocadherin XY shows that gene duplication 
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and divergence may be an important contributor to the phenotypic differences between 
the two species. 
 
Other ideas of genetic differences between humans and chimpanzees include changes in 
the functional amino acids (Hellmann et al. 2003). An example of this that may have 
contributed to differences between humans and chimpanzees is seen in the highly 
conserved transcription factor forkhead box protein P2 (FOXP2) (Enard et al. 2002b; 
Zhang et al. 2002). Two amino-acid changes have been reported in FOXP2 in the human 
lineage, and genetic studies have implicated this protein in playing a role in human 
speech and language (Lai et al. 2001; Vargha-Khadem et al. 2005). The amino-acid 
changes in FOXP2 indicate that this protein may have been targeted for selection during 
recent human evolution.   
 
Genome comparison studies confirm few genetic changes between humans and 
chimpanzees  
Further clues to the differences between human and chimpanzees have come from whole 
genome comparison of human and chimpanzee genomes (Lander et al. 2001; Mikkelsen 
et al. 2005). 
 
Initial observations from human whole genomic sequencing studies 
With the advent of whole genome sequencing technologies, the initial draft of the human 
genome was published in 2001 (Lander et al. 2001; Venter et al. 2001). In-depth analyses 
of the chromosomes were done following the release of the initial draft, and in 2006, the 
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finished sequence of the human genome was made available (Muzny et al. 2006). Some 
of the major observations from this sequencing study were: 
1. The human genome consists of 3.2 billion chemical nucleotides, i.e., adenine 
(Ad), guanine (Gu), thymine (Th) and cytosine (Cy).  
2. The landscape of the human genome shows marked variation in the distribution of 
a number of features that include genes, transposable elements (mobile genetic 
elements that can move from one location to another location in the genome), 
CpG islands, GC content and recombination rates. 
3. The number of genes in the human genome is 23,000-25,000.  
4. Approximately 2% of the sequences in the human genome code for proteins. 
5. Genes appear to be concentrated in random areas along the genome with vast 
expanses of non-coding DNA in between. 
6. The number of single nucleotide polymorphisms (SNPs) identified is 
approximately 1.4 million. 
7. Hundreds of genes appear to have resulted from horizontal transfer from bacteria 
at some point in the vertebrate lineage. Dozens of genes appear to have been 
derived from transposable elements. 
8. Even though transposable elements make up approximately 50% of the human 
genome, there is a marked decline in the overall activity of these elements in the 
hominid lineage. DNA transposons and long-terminal repeat (LTR) 
retrotransposons may have become inactive in the human genome. Short 
interspersed nuclear elements (SINEs) make up 13% of the human genome and 
the Alu elements seem to be the most abundant SINE elements. 
 10 
9. Segmental duplications are much more frequent in humans than in the yeast, fly 
or worm. 
Human and chimpanzee whole genome comparisons show very few differences 
Following the sequencing of the human genome, a logical follow-up was to sequence 
other related animals to better understand the evolutionary biology and unique features of 
humans. Given the near 99% similarity (King and Wilson 1975; Yunis et al. 1980; Britten 
2002; Fujiyama et al. 2002) that humans share with the chimpanzees, there was a 
recommendation by the scientific community (McConkey and Varki 2000; Normile 
2001; Olson and Varki 2003) to sequence the chimpanzee genome. By comparing the 
human and chimpanzee genomes, researchers felt that genes that contribute to human 
characteristics could be identified.  
 
The initial draft of the chimpanzee genome was published in 2005 (Mikkelsen et al. 
2005) and initial comparisons between the human and chimpanzee genomes have 
revealed the following observations: 
1. About 30% of all human proteins are identical in sequence to their   chimpanzee 
orthologs. Typical human and chimpanzee orthologs differ by only two amino acids 
on average. 
2. The difference between human and chimpanzee genomes due to single nucleotide 
substitutions is 1.23%, of which 1.06% is due to fixed divergence and the rest is due 
to polymorphisms within either species. 
 11 
3. Insertion and deletion  (INDEL) events account for approximately 3% of the 
differences between the two species. The number of genetic changes due to INDELs, 
however, is fewer compared to the changes due to single nucleotide substitutions. 
4. The rate of transposable element insertions is different between the two genomes, 
with the SINEs being threefold more active in the humans, whereas the chimpanzees 
have acquired two new families of retroviral elements.  
5. Several loci in the human genome were identified as potential candidates for selective 
sweeps in recent human history. 
 
Need for comparison with an out-group species 
There is a problem in comparing the genomes of closely related species like the humans 
and chimpanzees. It is difficult to determine whether the genetic changes in either 
genome are due to changes in the human lineage or due to changes in the chimpanzee 
lineage, once the species diverged from their common ancestor. Comparing the human 
and chimpanzee genome sequences with a not-too-distantly related common ancestor  
(out-group species) would resolve this problem. Potential out-group genome species 
include the orangutan, which diverged from the human lineage 14 MYA, and the rhesus 
macaque, which diverged from the human lineage 25 MYA. 
 
A draft sequence of the rhesus macaque (Macaca mulatta) – a type of Old world Monkey 
– was published in 2007 (Gibbs et al. 2007). Initial comparisons between human and 
rhesus macaque genomes have revealed that the sequence identity is approximately 93%, 
which is reduced to approximately 90%, if INDELs are taken into account. Like the 
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human and chimpanzee genomes, transposable elements constitute approximately 50% of 
the rhesus macaque genome, with the endogenous retroviruses having acquired some new 
families. The genomes of orangutan, gorilla and marmoset are being sequenced and are in 
early stages of completion (Varki 2007). 
 
Human and chimpanzee gene expression comparison show an accelerated gene 
expression change in human brain evolution 
As noted from independent (King and Wilson 1975; Yunis et al. 1980; Britten 2002; 
Fujiyama et al. 2002) and whole genome comparison studies (Mikkelsen et al. 2005), the 
sequence divergence between human and chimpanzee genomes is very little. It has been 
proposed that the phenotypic differences between the two species may be due to 
differences in gene regulation (King and Wilson 1975). Differences in gene regulation 
between humans and chimpanzees have been reported by microarray analysis studies 
(Enard et al. 2002a; Caceres et al. 2003; Khaitovich et al. 2004; Uddin et al. 2004). Most 
of these differences are reported in the brain. 
 
Genes involved in control of brain size have different amino acid substitutions in the 
human lineage 
One of the major anatomical differences between the human and chimpanzees is the 
exceptionally large size of the human brain (Figure 1.2). Estimates show that the human 
brain on average is three times as large as the chimpanzee brain (Carroll 2003; de Sousa 
and Wood 2007). The cerebral cortex, which is involved in memory, language and 
attention, is far larger in the humans than the chimpanzees and contains 50% more 
neurons (Preuss et al. 2004). It has been shown that two genes involved in the control of 
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brain size - abnormal spindle-like-microcephaly associated protein (ASPM) gene and the 
microcephalin gene - have an unusual pattern of amino acid substitution in the human 







Figure 1.2: Comparison of the a) human and b) chimpanzee brains shows that 




Differences in brain function between humans and chimpanzees may be due to gene 
regulation differences 
Differences in gene regulation between humans and chimpanzees can be studied by DNA 
microarray technology, which allows researchers to quantify the expression levels of 
thousands of genes simultaneously and to assess the role of gene-expression changes in 
evolution (Preuss et al. 2004). Much of our understanding of the differences in gene 
expression between human and chimpanzee brain function has come from microarray 
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studies (Enard et al. 2002a; Caceres et al. 2003; Karaman et al. 2003; Marvanova et al. 
2003). Some of the major conclusions from these studies were: 
1) The rate of gene expression changes in the brain accelerated during human 
evolution. 
2) Gene expression changes in the evolution of the human brain primarily involved 
an up-regulation of expression. 
3) Approximately 2-4% of the genes show differential expression between humans 
and chimpanzees in the cerebral cortex. 
 
In one of the first studies done to understand the gene expression differences between 
human and chimpanzees (Enard et al. 2002a), the authors concluded that more 
pronounced changes in gene expression occurred in the human lineage, specifically in the 
brain. It was also shown that the gene expression changes in the liver accumulated at 
equal rates in both species, thus suggesting that the brain may be one of the tissues where 
expression changes are more profound. Later, in another study (Gu and Gu 2003), it was 
shown that the number of significant expression changes in the brain was threefold higher 
in humans than in chimpanzees.  
 
From the above studies (Enard et al. 2002a; Caceres et al. 2003), it was also shown that 
majority of the genes that are differentially expressed in human and chimpanzee cerebral 
cortices show an increased level of expression in the human lineage. Conversely, gene 
expression analysis of liver and heart samples showed no evidence of an increased level 
of expression, with similar proportion of genes showing changes in expression in either 
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direction. A gene ontology analysis revealed that most of the genes showing an up- 
regulation in the human brain are involved in neuronal function and synaptic activity. 
However, Uddin and colleagues reported an increased down-regulation of genes in the 
human lineage, rather than an up-regulation (Uddin et al. 2004). Two of the flaws of this 
study (Uddin et al. 2004) were that the sample size of the individuals was small and that 
the down-regulation of expression could be explained by the fact that the focus of the 
results of this study was on small expression changes (Preuss et al. 2004).  
 
In one of the most comprehensive microarray studies (Khaitovich et al. 2005) done to 
correlate the sequence differences between the two species with expression differences, it 
was shown that significant differences in gene expression patterns exist between humans 
and chimpanzees especially in organs (e.g., brain and testes) that can be correlated to 
difference in functions (e.g., cognitive ability and fertility).  
 
One cautionary note about the microarray studies is the fact that the probes on the 
microarray are human-specific, and sequence mismatches between human probes and 
non-human primate mRNA can give a false indication that the gene is expressed at lower 
levels in the non-human primates than humans. In such cases, the data should be 
normalized, and the results should be confirmed by other techniques like Northern Blot or 
quantitative real time polymerase chain reaction (qrt-PCR). An alternate approach would 




Apoptosis is involved in both brain development and disease 
It has been postulated that the most profound changes in human brain evolution have 
probably involved changes in expression of genes that function early in development 
(Preuss et al. 2004). Thus, a focus on the mechanisms of development may shed more 
light on the differences between human and chimpanzee brain evolution.  
 
The mechanism of apoptosis 
Programmed cell death (PCD) or apoptosis is considered as a vital component of various 
processes including normal cell turnover, proper development and functioning of the 
immune system and the development of the nervous system (Elmore 2007). Apoptosis is 
a tightly regulated mechanism and has many biochemical and cellular features associated 
with it.  
 
One of the first cellular features of apoptosis that was identified was the fragmentation of 
DNA into nucleosomal fragments. This feature is used as a biochemical marker of 
apoptosis (Wyllie 1980). DNA fragmentation, however, is one of the end products of 
apoptosis, and a cell goes through various morphological changes during apoptosis 









The early stages of apoptosis are marked with cell shrinkage and chromatin condensation 
(pyknosis) (Kerr et al. 1972). This is followed by extensive plasma blebbing and nuclear 
membrane fragmentation (karyorrhexis). The cell fragments separate into apoptotic 
bodies during “budding”. These apoptotic bodies are then phagocytosed by macrophages, 
parenchymal cells or neoplastic cells and degraded within the phagolysosomes. The 
cellular changes that occur during apoptosis can be identified by light and electron 
microscopy and are used to identify and distinguish apoptosis from necrosis. Necrosis is 
another form of cell death that involves an inflammatory reaction, followed by a release 
of cellular constituents into the surrounding interstitial tissue (Kerr et al. 1972; Elmore 
2007). 
 
Research indicates that there are two main apoptotic pathways: the extrinsic or death 
receptor pathway and the intrinsic or mitochondrial pathway (Kerr et al. 1972) (Figure 
1.4). There is evidence that these two pathways are linked and that molecules of one 
pathway may influence molecules of the other pathway (Igney and Krammer 2002). Both 
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these pathways involve the activation of initiator and executioner caspases, and the 
pathways converge at the execution phase of the apoptotic cascade. The execution phase 







Figure 1.4: The two main apoptotic pathways-extrinsic and intrinsic (Putcha et al. 





Caspases are a group of proteases, whose enzymatic properties are governed by a 
dominant specificity for substrates containing aspartate (Asp) residues. Caspases use a 
cysteine (Cys) side chain for their enzymatic activity (Salvesen and Dixit 1997; 
Thornberry et al. 1997). Caspases are further classified as initiator (caspase-8, -9, -10 and 
-2) and executioner caspases (caspase-3, -6 and -7), depending on their position and role 
in the apoptotic cascade (Salvesen 2002).  In the cells caspases are present as inactive 
zymogens and are activated either by autocatalysis or by other proteins in the apoptotic 
cascade. 
 
The extrinsic apoptotic pathway initiates apoptosis on the cell surface via death receptors. 
These receptors are members of the tumor necrosis factor (TNF) receptor gene super 
family (Locksley et al. 2001). Members of the TNF receptor super family have a 
cytoplasmic domain of 80 amino acids called the death domain (Ashkenazi and Dixit 
1998), which is involved in transmission of the death signal from the cellular surface to 
the intracellular signaling pathways. The Fas ligand (FasL) and receptor (FasR) are one 
of the best-characterized ligand and receptors of the TNF super family (Chicheportiche et 
al. 1997). Binding of FasL with FasR results in the binding of Fas associated with death 
domain (FADD) protein with the ligand-receptor complex. FADD then associates with 
procaspase- 8, forming a death-inducing cell signaling complex (DISC), which results in 
the autocatalytic activation of procaspase-8 to caspase-8 (Kischkel et al. 1995). The 
activated initiator caspase-8 activates the execution phase of the apoptotic pathway. The 
extrinsic apoptotic pathway can be inhibited by cellular caspase-8 like inhibitory protein 
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(c-FLIP), which binds to FADD and caspase-8, rendering them ineffective (Kataoka et al. 
1998; Scaffidi et al. 1999). 
 
A number of intracellular signals such as stress or DNA damage initiate the intrinsic 
apoptotic pathway. These signals may act in a positive or negative fashion and act 
directly on targets within the cell, usually the mitochondria (Liu et al. 2003). The 
intracellular signals cause changes in the inner mitochondrial membrane that results in 
the opening of the mitochondrial permeability transition (MPT) pore and the release of a 
number of pro-apoptotic proteins, chief among them being the cytochrome C, second 
mitochondria-activator of caspases (Smac) or Diablo and the apoptosis inducing factor 
(AIF) proteins (Yang et al. 1997; Du et al. 2000; van Loo et al. 2002).  
 
On release from the mitochondria, cytochrome C activates the apoptosis-activating factor 
1 (Apaf1) as well as procaspase-9 to caspase-9, forming a multi-complex protein 
structure called the apoptosome (Chinnaiyan 1999; Hill et al. 2004). The apoptosome 
then activates the execution phase of the apoptotic pathway. The Smac/Diablo protein is a 
pro-apoptotic factor and prevents the inhibitor of apoptosis (IAP) group of proteins from 
inactivating the intrinsic pathway. On the other hand, AIF translocates to the nucleus and 
causes DNA fragmentation in a caspase independent manner (Joza et al. 2001).  
 
The control and regulation of apoptotic mitochondrial events occur through members of 
the B-cell lymphoma 2 (Bcl-2) family of proteins (Cory and Adams 2002). Members of 
this family can either be pro-apoptotic, e.g., Bcl-2 associated X protein (Bax), BH3 
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interacting domain death agonist (Bid) and Bcl-2 associated death promoter (Bad), or 
they can be anti-apoptotic, e.g., Bcl-2, B-cell lymphoma-extra large (Bcl-xL) and Bcl2-L2 
(Bcl2-Like 2). It is thought that the Bcl-2 family of proteins alters the mitochondrial 
membrane permeability, which results in the release of cytochrome C from the 
mitochondria.  
 
Both the extrinsic and intrinsic apoptotic pathways converge at the execution phase, 
which is considered as the final phase of the apoptotic pathway and involves the 
activation of the executioner caspases: caspase-3, -6 and -7. These caspases cleave 
various substrates, including cytokeratins and a DNA repair protein called poly ADP 
ribose polymerase (PARP), resulting in the biochemical changes seen in apoptotic cells 
(Slee et al. 2001). 
 
Apoptosis in development 
It has long been recognized that apoptosis plays a critical role in normal animal 
development (Elmore 2007). The developmental roles that apoptosis plays include the 
removal of unneeded structures and the shaping of existing structures to control cell 
number and organ size (Jacobson et al. 1997). The apoptotic process is highly conserved 
and orthologs of the various key apoptotic proteins are found in other organisms like 
yeast and fly (Meier et al. 2000).    
 
Apoptosis has been known to occur during the normal development of the vertebrate 
nervous system (Oppenheim 1991). Traditional views of neural development have 
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focused on survival factors such as nerve growth factors and neurotrophins (Snider 
1994). Traditionally, it was believed that during neural development, apoptosis is merely 
a mechanism to match neuronal populations to their target fields and that it plays a role in 
eliminating neurons with erroneous or inadequate projections (Cowan et al. 1984; Raff 
1992). Recent studies have shown that apoptosis is an important mechanism involved in 
adjusting the initial pool of progenitor neuron cells for the proper morphogenesis of the 
nervous system (Cecconi et al. 1998; Yoshida et al. 1998; Kuan et al. 1999; Sabapathy et 
al. 1999). 
 
It is known that in mammals, the intrinsic apoptotic pathway plays an important role in 
the formation of the nervous system (Haydar et al. 1999; Kuan et al. 2000; Putcha et al. 
2002; Lossi and Merighi 2003). Most of the evidence for this has come from knockout 
studies done on mice. Mice carrying Apaf1 mutations display a failure of neural tube 
closure as well as an overgrowth of the forebrain (Cecconi et al. 1998; Yoshida et al. 
1998; Honarpour et al. 2001). Caspase-9 knockout mice also show brain overgrowth, and 
this overgrowth appears as cortical folds (Kuida et al. 1998). Caspase-3 knockout mice 
also display neuronal overgrowth and disorganization (Kuida et al. 1996).  
 
Studies extended to primates also show that the intrinsic apoptotic pathway plays a role in 
brain development, especially in the development of the neocortex (Rakic and Zecevic 
2000; Chan et al. 2002). In a study done to understand the molecular evolution of the 
mammalian intrinsic apoptotic pathway, it was shown that Apaf1 and caspase-3 might 
have undergone accelerated evolution in the human lineage (Vallender and Lahn 2006). 
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Apoptosis in disease 
Just like any other pathway, a misregulation of the apoptotic pathway can lead to a 
number of diseases, chief among them being neurodegenerative diseases (Nijhawan et al. 
2000) and cancer (Lowe and Lin 2000). Some of the neurodegenerative diseases that 
exhibit a misregulation of the apoptotic pathway are Huntington’s, Parkinson’s and 
Alzheimer’s. All of these diseases display a Mendelian form of inheritance and are 
associated with the loss of particular neuronal subtypes. In studies done on transgenic 
mice, it has been shown that in Huntington’s disease, genes that code for caspase-1 and -
3 are up-regulated during early as well as later stages of the disease (Ona et al. 1999; 
Chen et al. 2000). Studies have also shown that the up-regulation of the caspases is 
followed by a release of cytochrome C (Ona et al. 1999). An up-regulation of the 
caspases and a related increased apoptotic turnover has also been shown in Parkinson’s 
disease (Klivenyi et al. 1999). In summary, an overall up-regulation of key apoptotic 
genes is seen in neurodegenerative diseases. 
 
In cancer, the apoptotic machinery is disrupted, resulting in tumor initiation, progression 
and metastasis (Lowe and Lin 2000). The tumor suppressor protein p53 is known to up-
regulate the expression of pro-apoptotic gene Bax in response to DNA damage and other 
stress signals. Bax in turn stimulates the mitochondria to release cytochrome C, and this 
triggers apoptosis. Consequently, a number of sub cellular structures and organelles are 
destroyed, including the ones where there is any form of stress or DNA damage. Thus, 
the fidelity of the genome is preserved. In a number of tumors, however, it has been 
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shown that p53 is mutated and its tumor suppressor function is lost (Wallace-Brodeur and 
Lowe 1999). This may explain the evasion of apoptosis in certain cancers. 
 
It has been shown by transgenic mice studies that the anti-apoptotic genes Bcl-2 and Bcl-
xL may be over-expressed in certain tumors (Vaux et al. 1988; McDonnell et al. 1989; 
Hockenbery et al. 1990). Bcl-2 promotes survival of cells through its anti-apoptotic 
properties. Conversely, it has been shown pro-apoptotic Bax is inactivated in certain 
colon cancers (Rampino et al. 1997; Meijerink et al. 1998). 
 
Humans show a higher susceptibility to cancer than chimpanzees (Seibold 1973; Puente 
et al. 2006). In humans, the deaths caused by certain neoplasms like breast, prostate and 
lung are more than 20%, compared to the incidences of these cancers in chimpanzees 
which is ~ 2% (McClure 1973; Seibold 1973; Beniashvili 1989). It was reported in a 
study that the chimpanzee gene encoding for p53 contains a proline (Pro) at codon 72, 
while in the humans this codon is polymorphic and can code for arginine (Arg) and Pro 
(Puente et al. 2006). In a comparison of the p53 sequence in a number of different 
primates, it was seen that the codon 72 codes for Pro, thus suggesting that this must be 
the ancestral allele and that the Arg72 allele must be unique to the human lineage. In the 
same study, it was shown that the breast cancer 1 (BRCA1) gene in the chimpanzee has a 
8kb deletion, the consequences of which are not known.  
 
From the above discussion, it is seen that the apoptotic pathway is involved in the 
development of the brain. Further, it has been shown that the human cerebral cortex 
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contains 50% more neurons than the chimpanzees (Preuss et al. 2004). In a study done on 
mice, it was shown that by disrupting the function of the caspases-3 and -9 in the brain, a 
decrease in the apoptotic function was observed resulting in an expansion of the forebrain 
(Kuan et al. 2000). The expansion of the forebrain was due to the survival of a specific 
type of forebrain progenitor cells.  
 
One question that arises is whether the difference in the number of neurons between 
humans and chimpanzees can be attributed to a difference in the apoptotic function 
between the two species as caused by one of the genes in the apoptotic pathway. If such a 
difference does exist, can it also explain the difference in susceptibilities that humans and 
chimpanzees have to diseases like cancer? Not much is known about the differences in 
the apoptotic function between the two species, and answers to these questions may help 
us better understand the differences in brain development and function as well as the 
difference in the susceptibilities that humans and chimpanzees have to diseases 
associated with apoptosis.  
 
Impact of INDELs on human and chimpanzee genomes 
From independent (Britten 2002) and sequencing studies (Mikkelsen et al. 2005), it was 
shown that INDELs account for approximately 4% of the differences between human and 
chimpanzee genomes and that INDELs may contribute to the phenotypic differences 
between the two species. INDELs consist of a number of nucleotides that are present in 
the genome (INsertion) of one organism but may be absent from the genome of a closely 
related species (DELetion). By using an out-group species, INDELs can be characterized 
more precisely.  
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Previous studies done to identify INDELs 
In one of the first studies done to identify human and chimpanzee INDEL variation, a 27 
Mb region of the human chromosome 21 was compared with chimpanzee DNA 
sequences, and approximately 57 INDELs were identified (Frazer et al. 2003). In the 
same study, a 9 Mb region of the human chromosome 21 was compared with DNA 
sequences from orangutan, rhesus macaque and wholly monkey, and 114 INDELs were 
identified.  
 
In a comparison of the high quality sequence of the chimpanzee chromosome 21 and the 
human chromosome 22, as many as 68,000 INDELs were identified (Watanabe et al. 
2004). Most of these INDELs were associated with SINE elements. Later on, in another 
study, small INDELs of size " 100 bp between the human chromosome 21 and the 
chimpanzee chromosome 22 were identified (Chen et al. 2007). This study used human-
chimpanzee-mouse-dog multiple sequence alignment to identify the human-specific 
INDELs. Most of the INDELs identified in this study are located in the intergenic region 
of the genome.  
 
In a recent comparison of human chromosome 21 and chimpanzee chromosome 22, as 
many as 6279 INDELs of size >10 bp were identified (Volfovsky et al. 2009). Many of 
these INDELs are located in the intron region of the genes. From the above studies, it has 
been shown that INDELs are made of transposable elements (TEs) and tandem repeats 
(Mills et al. 2006a). 
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Transposable elements and their impact on human chimpanzee genome evolution 
From sequencing (Lander et al. 2001; Venter et al. 2001; Mikkelsen et al. 2005; Gibbs et 
al. 2007) as well as independent studies (Bonner et al. 1982; Holmes et al. 1994), it was 
shown that approximately 50% of the primate genomes contain TEs. It has also been 
recognized that TEs may be important factors in regulatory evolution and hence have the 
capacity to alter gene expression (McClintock 1984; Bowen and Jordan 2002; van de 
Lagemaat et al. 2003) among other functions. 
 
First discovered in 1944 by Barbara McClintock (Mc 1950), TEs were initially thought to 
be genomic parasites. It was observed that these elements could out-replicate and spread 
in natural populations with a selective disadvantage to the host organisms (Hickey 1982). 
However, later on, an adaptive role of these elements in the host genomes emerged 
(McDonald 1993; Kidwell and Lisch 2000; Kidwell and Lisch 2001). It was shown that 
TEs are important contributors in Drosophila telomere maintenance (Pardue et al. 1987) 
and in mammalian DNA repair (Morrish et al. 2002). A new role of these elements in the 
evolution of epigenetic mechanisms is now emerging (Finnegan 1992; Huda and Jordan 
2009; Huda et al. 2009).  
 
TEs can be classified on the basis of their mechanism of movement in the host genomes: 
as Class I elements that consists of retrotransposons, or as Class II elements that consists 
of DNA transposons (Finnegan 1992). Retrotransposons move throughout the genome 
via an RNA intermediate, whereas the DNA transposons move through a “cut and paste” 




Figure 1.5: Mechanism of movement of a) DNA transposon and b) Retrotransposon 




Class I elements are further classified into two groups: a) LTR retrotransposons/ 
endogenous retroviruses and b) non-LTR retrotransposons (Figure1.6) (Deininger and 
Batzer 2002). The non-LTR retrotransposons consist of long interspersed nuclear 
elements (LINEs) and SINEs. The LTR retrotransposon/ endogenous retroviruses and 
LINEs are autonomous in the sense that they encode their own reverse transcriptase 
enzyme for transcription, whereas the SINEs depend on the reverse transcriptase from the 
LINEs and hence are non- autonomous. For a long time, it has been known that 
retrotransposons have played an essential role in the evolution of mammalian gene 









From sequencing studies, it is known that a particular class of SINE elements- the Alu 
element- is threefold more active in the human genome than in the chimpanzee genome, 
whereas the chimpanzees have acquired two new families of endogenous retroviruses 
(Mikkelsen et al. 2005).  In a study done to classify recently inserted transposable 
elements between humans and chimpanzees, it was shown that humans have a greater 
rate of insertions compared to chimpanzees, and the majority of these insertions are in or 
around genes (Mills et al. 2006a). Most of these insertions were associated with Alu 
elements. Further, in a previous study from our lab (Polavarapu et al. 2006), it was shown 
that transposable elements, in particular retrotransposons, have contributed significantly 
to the INDEL variation that exists between humans and chimpanzees. 
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Tandem repeats and INDEL variation between humans and chimpanzees 
Tandem repeats are adjacent patterns of two or more nucleotides that are repeated 
throughout the DNA (Benson 1999) and consist ~3% of the human genome (Lander et al. 
2001).  
In recent years the role of trinucleotide repeats in diseases like Huntington’s (Trottier et 
al. 1994), fragile-X mental retardation (Verkerk et al. 1991) and myotonic dystrophy (Fu 
et al. 1992) has increased the interest in tandem repeats. It is known that tandem repeats 
also play roles in the development of the immune system cells (Verstrepen et al. 2004), 
and their potential roles in the evolution of social-sexual behavior among the humans and 
bonobos are now emerging (Hammock and Young 2005).  
 
Tandem repeats have been known to play roles in the regulation of gene expression by 
either interacting with transcription factors, altering chromatin structure or acting as 
potential protein binding sites  (Hamada et al. 1984; Pardue et al. 1987; Yee et al. 1991). 
They are known to contribute to the INDEL variation that exists between humans and 
chimpanzees (Madsen et al. 2008). 
 
From the above discussion, it is clear that INDELs contribute to the variation between 
human and chimpanzee genomes. INDELs made up of either TEs or tandem repeats are 
usually located in or near genes. The role that INDELs play in differential gene 
expression between humans and chimpanzees has not been studied in  detail. Given the 
very little sequence divergence between the two species, correlating INDEL variation 
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with differential gene expression  may help us better understand the genetic basis of the  
phenotypic differences between the two species. 
 
Analysis of the differences in apoptotic function between humans and chimpanzees 
and a role that INDELs may play in gene regulation differences between the two 
species. 
One of the major phenotypic difference between humans and chimpanzees is the 
exceptionally large human brains and the associated higher cognitive functions (Gagneux 
and Varki 2001; Hacia 2001; Carroll 2003; de Sousa and Wood 2007; Varki 2007). In 
addition humans have a high susceptibilty to neurodegenerative diseases like 
Huntington’s and Alzheimer’s (Gearing et al. 1994; Poduri et al. 1994; Walker 1999) and 
other diseases like cancer (Lowe and Lin 2000).  One pathway that is common to both the  
development of the brain and these diseases is the apoptotic pathway (Kerr et al. 1972; 
Elmore 2007). It has been proposed that an understanding of the mechanisms involved in 
the development of the brain may shed more light on the human chimpanzee brain 
evolution  (Preuss et al. 2004). This dissertation looks at the differences in the apoptotic 
function between humans and chimpanzees and uses both computational and 
experimental tools to assess these differences. 
 
Chapter 2 details a re-analysis of a previous microarray study (Khaitovich et al. 2005). 
The microarray expression data for this previous study was obtained from five 
chimpanzee and six human tissue samples. In the re-analysis the known expression 
differences between humans and chimpanzees are overlaid on pathways like apoptosis to 
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see whether a difference in apoptotic function is seen between the two species. The 
results from this analysis suggest that the apoptotic function  may be reduced in humans 
compared to chimpanzees. 
 
In chapter 3, the hypothesis that the apoptotic function may be reduced in humans is 
tested on human, chimpanzee and macaque primary fibroblasts cells, using a number of 
apoptotic assays and techniques. The results are consistent with the differential apoptotic 
hypothesis that humans have a reduced apoptotic function, compared to both 
chimpanzees and macaques. 
 
Chapter 4 describes a study where the INDEL variation between humans and 
chimpanzees is identified. This is the first study that uses macaque genome sequence as 
an out-group to characterize the INDEL variation between humans and chimpanzees and 











DID NATURAL SELECTION FOR INCREASED COGNITIVE 




Despite the overall genetic similarity that exists between humans and chimpanzees, the 
species are phenotypically distinct. Among the most notable distinctions are differences 
in brain size and cognitive abilities. Previous studies have shown that significant 
differences in gene expression exist between the human and chimpanzee brain. 
Integration of currently available gene expression data with known metabolic 
and signaling pathways indicates that the expression of genes involved in the 
programmed cell death of brain neurons is significantly different between humans and 
chimpanzees and predictive of a reduced level of neuron apoptosis in the human brain. 
This pattern of expression is generally maintained in other human organs suggesting that 
apoptosis is reduced in humans relative to chimpanzees. We propose that a decreased rate 
of programmed neuron death may have been a consequence of selection for increased 
cognitive ability in humans. Since reduced apoptotic function is associated with an 
increased risk of cancer and related diseases, we hypothesize that selection for increased 
cognitive ability in humans coincidently resulted in an increased risk of cancer and other 





Over the ~6 million years that the human and chimpanzee lineages have diverged from a 
common ancestor, the two species have evolved a variety of distinctive phenotypic traits 
(Graves 1986; Wood and Collard 1999). Some of these differences are obviously 
adaptive, e.g., the larger size of the human brain and associated increase in cognitive 
abilities (Waters et al. 1998; Preuss 2000; Williams 2002; Herrmann et al. 2007) while 
others are less easily explained, e.g., the fact that humans are inherently more prone to 
developing cancer than chimpanzees (McClure 1973; Seibold 1973; Beniashvili 1989; 
Waters et al. 1998). 
 
In an effort to understand the molecular bases of the phenotypic differences that 
distinguish humans from chimpanzees, a number of comparative genomic studies have 
been conducted in recent years (Enard et al. 2002a; Yan et al. 2002; Preuss et al. 2004; 
Khaitovich et al. 2005). For example, Khaitovich et al. (Khaitovich et al. 2005) have 
shown that significant differences in gene expression patterns exist between humans and 
chimpanzees in tissues (e.g., brain and testes) associated with traits (e.g., cognitive ability 
and fertility) distinguishing the two species. Our pathway reanalysis of these data 
suggests that genes involved in apoptotic function are generally lower in expression in 
humans relative to chimpanzees. In this paper, we discuss the possible significance of 
these findings and hypothesize how they may help explain the relative increased risk 





Comparisons of gene expression patterns between human and chimpanzee brains suggest 
that increased cognitive ability in humans may be explained, at least in part, by a 
reduction in the level of programmed cell death in the human brain. Similar differences 
in gene expression patterns in other tissues indicate that the relative reduction in 
apoptotic function in humans may extend beyond the brain to other tissues. It has been 
previously noted that cancer and other diseases associated with reduced apoptotic 
function rarely occur in chimpanzees (McClure 1973; Seibold 1973; Beniashvili 1989; 
Waters et al. 1998). We hypothesize that these two observations may be linked and that a 
bi-product of natural selection for increased brain size and cognitive ability in humans 
was an elevated propensity for cancer and other diseases associated with reduced 
apoptotic function. 
 




An extensive analysis of gene expression patterns between humans and chimpanzees was 
conducted by Khaitovich et al.(Khaitovich et al. 2005). A major goal of this previous 
study was to correlate sequence differences with expression differences and a number of 
microarray probe sets for which quality sequence could not be obtained in humans and 
chimpanzees (e.g., required for the calculation of ka/ks values) were excluded. Since the 
quality of the chimpanzee genome sequence has improved in recent years, and because 
our focus of interest is on the potential adaptive significance of chimpanzee–human 




The most dramatic difference in gene expression between humans and chimpanzees is in 
testis (62% of genes display a significant difference in expression) followed by heart 
(35%), brain (34%), kidney (33%) and liver (25%) (Table 2.1). To better understand 
the possible significance of the gene expression differences in the brains of the two 
species, we integrated the microarray data with known metabolic and signaling pathways. 
The results indicate that a number of the genes differentially expressed between the 
human and chimpanzee brains have been previously associated with human cognitive 
diseases including Parkinson’s disease and Huntington’s Chorea (TableA.1, Appendix 
A). It has been previously shown that the expression of genes predicted to induce 
apoptosis are elevated in the brains of cognitively impaired Parkinson’s, Huntington’s 
and Alzheimer’s patients and in experimental (mouse) models of these diseases 
(Nijhawan et al. 2000; Cadet et al. 2001; Jayanthi et al. 2001; Kiechle et al. 2002; Reddy 


















Table 2.1:Differentially expressed genes between humans and chimpanzees across 
five organs. The human–chimpanzee gene expression data (.cel files) for five different 
tissues (i.e. brain, heart, liver, kidney and testis) in six humans and five chimpanzees 
were kindly provided (Khaitovich et al. 2005). The data were processed using the MAS 
normalization method encoded in the Affymetrix function library of the Bioconductor 
package (http://www.bioconductor.org/) developed for R statistical programming 
environment (http://www.r-project.org/). To insure the validity of the comparative gene 
expression levels, probes with sequences that differ between humans and chimpanzees 
were excluded from the analysis as previously described (Khaitovich et al. 2005). Only 
genes with detection p-values of less than 0.065 were considered for further analysis. 
Gene expression values were normalized across samples by Z-score calculation using 
Spotfire Decision Site software (http://spotfire.tibco.com/index.cfm). Genes with t-test, 
p-values of less than 0.01 between human and chimpanzees were considered 
differentially expressed. 
 
 Brain Heart Liver  Kidney  Testis 
Detected 10231 9580 9451 10546 12509 
Dif Exp 3519 3361 2385 3458 7783 




To directly explore the possible consequence of the differences in gene expression 
between humans and chimpanzees on apoptotic function, we overlaid the gene expression 
differences between chimpanzee and human brains onto the human apoptotic-signaling 
pathway. Thirty-seven of the genes differentially expressed between human and 
chimpanzee brains were found to be components of the extrinsic or intrinsic apoptotic 
pathway (Tables 2.2 and 2.3, Figure 2.1). For example, cytochrome C (CYCS), a gene 
that is significantly down-regulated in the human brain, is the major initiator in the 
caspase-dependent intrinsic apoptotic pathway. A gene set enrichment analysis (GSEA) 
(http://www.broad.mit.edu/gsea/) further confirmed that our set of differentially 
expressed genes is significantly enriched for genes previously associated with apoptosis 
(p-value = 1.21 * 10-16). 
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Table 2.2: Genes differentially expressed between human and chimpanzee brains 
previously associated with the apoptotic pathway. The postulated function of each 
encoded protein in the apoptotic pathway (I = inducer of apoptosis; R = repressor of 
apoptosis) was obtained from the Ingenuity gene explorer annotations (S) 
(http://www.ingenuity.com/) and independently verified using the annotations at The  
Atlas of Genetics and Cytogenetics in Oncology and Haematology (A) 
(http://atlasgeneticsoncology.org/index.html) and/or by literature search. 
 
Gene Symbol 
(alias) Gene Name Location in Human 
Genome 
Function 
1.AIFM1 Apoptosis inducing 
factor mitochondrion 
associated, 1 
chrXq25-q26 IS, A 
2.BID  BH3 interacting 
domain death agonist 
chr22q11.1 IS, A 
3.CAPN2 Calpain 2 chr1q41-q42 IS, A 
4.CAPN3 Calpain 3 chr15q15.1-q21.1 IS, A 
5.CAPN5 Calpain 5 chr11q14 IS, A 
6.CAPN7 Calpain 7 chr3p24 IS, A 
7.CASP2 Caspase 2, apoptosis 
related cysteine protease 
chr7q34-q35 IS, A 
8.CASP6 Caspase 6, apoptosis 
related cysteine protease 
chr4q25 IS, A 
9.CASP9 Caspase 9, apoptosis 
related cysteine protease 
chr1q36.3-p36.1 IS, A 
10.CYCS Cytochrome C, somatic chr7p15.3 IS, A 
11.DIABLO Diablo homolog 
(Drosophila) 
chr12q24.31 IS, A 
12.HTRA2 HtrA serine peptidase 2 chr2p12 IS, A 
13. MKK7           
(MAP2K7) 
Mitogen-activated 
protein kinase kinase 2 




protein kinase kinase 
kinase 3 
chr6q22.33 IS, A 
15.MAP4K4 Mitogen-activated 
protein kinase kinase 




















protein kinase 8 
chr10q11.2 IS, A 
19.R-RAS 
(MRAS) 
Muscle RAS oncogene 
homolog 
chr3q22.3 I35 
   IS,A 
20.PRKCE Protein kinase C,epsilon chr2p21 IS,A 
21.SPTAN1 Spectrin alpha, non-
erythrocytic 1 (alpha 
fodrin) 
chr9q33-q34 RS,A 
22.XIAP (BIRC4) Baculoviral IAP repeat-
containing 4 
chrXq25 RS,A 
23.IKKA (CHUK) Conserved helix-loop-
helix ubiquitous kinase 
chr10q24-q25 RS,A 
24.DDR1 Discoidin domain 
receptor tyrosine kinase 
1 
chr6p21.3 RS,A 
25.DDR2  Discoidin domain 
receptor tyrosine kinase 
2 
chr1q23.3 RS,A 
26. ICAD (DFFA)  DNA fragmentation 





Fibroblast growth factor 
receptor 2 
chr10q26 RS,A 
28.KRAS v-ki-ras2 Kirsten rat 
sarcoma viral oncogene 
homolog 




protein kinase kinase 2 
chr19p13.1 RS,A 
30.RAF1 v-raf-1 murine leukemia 
viral oncogene homolog 
1 
chr3p24 RS, A 
31. NF&B (RELA) Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 3 
chr11q-q13 RS, A 
32. TEK TEK tyrosine kinase, 
endothelial 
chr9p21 R36 







Table 2.2 continued 
34.IKBKB Inhibitor of kappa light 
polypeptide gene 
enhancer in B cells, 
kinase B 
chr8p11.2 RS, A 
35.PARP1 Poly (ADP-ribose) 
polymerase family 
member 1 
chr1q41-q42 RS, A 
36.TYRO3 TYRO3 protein tyrosine 
kinase 
chr15q15.1-q15.2 RS,A 
37.PDGFRA Platelet-derived growth 














Figure 2.1: Apoptotic pathway genes are differentially expressed in the human and 
chimpanzee brains consistent with a model of reduced neuron cell death in the 
human brain. Red nodes indicate genes displaying relatively higher levels of expression 
(p < 0.01) in human brain; green nodes indicate genes displaying relatively lower levels 
of expression (p < 0.01) in human brain. Pathways were constructed using 





Twenty-one of the 37 apoptotic genes displaying differences in expression between 
human and chimpanzee brains have been characterized previously as inducers of 
apoptosis and 16 (76%) of these are down-regulated in the human brain (Table 2.3). 
Sixteen of the 37 genes have been characterized previously as repressors of apoptosis and 
9 (56%) of these genes are up-regulated in the human brain. It has been proposed that 
natural selection for increased cognitive ability in humans resulted in an elevated rate of 
brain neuron synthesis (Williams 2002). Our findings are consistent with the hypothesis 
that a decreased rate of programmed neuron death may have been an additional 




Table 2.3: Differences in the expression of apoptotic pathway genes between human 
and chimpanzee brains are conserved across tissues. Shown are log-ratio values 
(average human log expression value minus average chimpanzee log expression value) of 
gene expression differences in human relative to chimpanzee. A negative value indicates 
down-regulation in humans relative to chimpanzees, while a positive value indicates up-
regulation in humans relative to chimpanzee. The function of each encoded protein in the 
apoptotic pathway (I = inducer of apoptosis; R = repressor of apoptosis) was obtained 
from Ingenuity gene explorer annotations (Ingenuity® Systems, 
http://www.ingenuity.com/) and independently verified using the annotations at The 
Atlas of Genetics and Cytogenetics in Oncology and Haematology 
(http://atlasgeneticsoncology.org/index.html) and/or by literature search (see Table 2.2 
for details). The direction of brain expression (+/-) differences with differences in 




Gene Symbol Function Heart Kidney Liver Testis Brain 
1.AIFM1 I -0.07 -0.35 -0.0056 0.48 -0.79 
2.BID I 0.25 -0.48 0.21 0.86 0.56 
3.CAPN2 I -0.63 -0.95 -0.56 -0.29 -0.63 
4.CAPN3 I -1.68 1.45 1.4 -0.67 1.22 
5.CAPN5 I -0.09 -0.59 0.74 0.89 -0.51 
6.CAPN7 I -0.37 -1.06 -0.39 -0.28 -0.39 
7.CASP2 I -1.52 -1.05 -0.16 -0.48 -1.44 
8.CASP6 I -1.38 -1.33 -1.53 -0.48 -1.78 
9.CASP9 I 0.14 0.23 -0.12 -0.031 -0.35 
10.CYCS I -0.52 -0.95 -0.7 -0.33 -1.18 
11.DIABLO I -0.79 -0.36 -0.12 -0.68 -0.51 
12.HTRA2 I -0.19 -0.43 -0.14 -0.73 -0.39 
13.MKK7 I -0.53 0.02 -0.25 0.26 -0.47 
14.ASK1 I 0.81 -0.33 0.53 0.78 0.75 
15.MAP4K4 I 0.33 0.21 0.77 1.64 0.89 
16.ERK1 I -0.39 -0.44 -0.17 0.036 -0.57 
17.ERK2 I -0.5 -0.05 -0.53 1.3 0.68 
18.JNK1 I 0.02 0.52 0.82 0.92 -0.51 
19.R-RAS I -0.27 -1.66 -0.88 -0.42 -1.14 
20.PRKCE I -0.74 -1.59 -0.11 -1.38 -0.74 
21.SPTAN1 I 0.11 0.12 -0.65 0.69 -0.14 
22.IAP R 1.75 1.02 0.53 1.87 2.08 
23.IKKA R 0.23 0.18 0.47 0.67 0.53 
24.DDR1 R -1.09 0.35 0.62 0.87 0.5 
25.DDR2 R 0.35 0.4 0.09 0.76 0.56 
26.ICAD R -0.41 -0.39 -0.12 0.09 -0.62 
27.FGFR2 R 0.23 -0.58 0.235 0.051 1.38 
28.KRAS R 0.035 0.35 0.61 0.77 0.93 
29.MEK2 R 1.17 0.65 -0.66 1.24 1.14 
30.RAF1 R 0.21 -0.1 -0.61 0.07 -0.46 
31.NF&B R -0.66 0.039 -0.23 0.29 -0.63 
32. TEK R 0.65 0.58 0.68 0.6 0.41 
33.EGFR R 0.07 1.02 0.75 1.81 0.87 
34.IKBKB R -0.42 -0.33 -1.77 0.33   -0.52 
35.PARP1 R 0.94 -0.33 -0.212 0.3 -0.32 
36.TYRO3 R -0.65 0.66 -0.13 0.97 -0.37 





To ascertain if the apparent reduction in apoptotic function between human and 
chimpanzee brains extends to other tissues, we analyzed the log-ratio values of the 37 
differentially expressed genes involved in the apoptotic pathway in heart, liver, kidney 
and testis (Table 2.3). The results indicate that the vast majority of the genes involved in 
apoptotic function that are differentially expressed in the human vs. the chimpanzee brain 
are similarly differentially expressed in the other organs (Table 2.3). For example, 11!of 
the 16 (69%) inducers of apoptosis that are down-regulated in the human brain are 
similarly down-regulated in at least three of the other four organs examined. All 9 
(100%) repressors of apoptosis that are up-regulated in the human brain are similarly up-
regulated in at least three of the four other organs examined. The overall correlation 
between the patterns of expression of the known inducers and repressors of apoptotic 
function between brain and the four other organs examined is highly significant (Table 2. 
3, p-value = 6.15 *10-11, Signs test; n+ = 82, n- = 18). 
 
Consequences of the hypothesis and discussion 
Since it is well known that reduced apoptotic function is associated with an increased risk 
of cancer and related diseases (Lowe and Lin 2000), our results are consistent with the 
hypothesis that selection for increased cognitive ability in humans may have coincidently 
resulted in an increased risk of cancer and other diseases associated with reduced 
apoptotic function. Consistent with our hypothesis is the recent observation that patients 
with human cognitive diseases associated with increased brain neuron apoptosis display 
significantly reduced rates of cancer (Driver et al. 2007; Eskenazi et al. 2007). 
Given that the onset of cancer typically begins well after the onset of reproductive age 
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(http://seer.cancer.gov/csr/1975_2005/), the negative selective cost of reducing apoptotic 
function to increase cognitive ability within the human lineage was most likely minimal. 
Since there is no apparent advantage to systemically reducing apoptotic function, the 
alternative hypothesis that a reduced rate of neuron death in humans could have been an 
indirect consequence of selection for reduced apoptotic function in other organs is 
unlikely. 
 
While differences in patterns of gene expression between humans and chimpanzees 
predict that apoptotic function is reduced in the human brain, additional laboratory 
studies as well sequence analysis (Table A.2 and Figure A.1) will be required to validate 
predictions from the gene expression studies. Moreover, as additional gene expression 
assays are conducted in other primates, it should be possible to test the hypothesis that 
reduced apoptotic function is a derived condition in the human lineage. 
 
In summary, recent comparative gene expression results between chimpanzees and 
humans are consistent with the view that natural selection for increased cognitive ability 
in humans was attained, at least in part, by a reduction in the level of programmed cell 
death in the human brain. Existing data indicate that this reduction in apoptotic function 
extends beyond the brain to other tissues and is consistent with an evolutionary 
hypothesis whereby natural selection for increased brain size and cognitive ability in the 
human lineage coincidently resulted in an elevated propensity for cancer and other 
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HUMAN CELLS DISPLAY A REDUCED APOPTOTIC FUNCTION 




Humans and chimpanzees differ in a number of phenotypic traits, among them being a 
larger sized human brain and an increased propensity for cancer in humans. Previously 
published gene expression analyses suggest that apoptotic function may be reduced in 
humans relative to chimpanzees and that this difference may account for both the 
relatively larger human brain and the increased propensity of humans to develop cancer.  
In this study, we directly test the hypothesis that humans maintain a reduced apoptotic 
function relative to chimpanzees by conducting a series of apoptotic function assays on 
human, chimpanzee and macaque primary fibroblastic cells. Human cells consistently 
displayed significantly reduced apoptotic function relative to the other primate cells. 
These results are consistent with earlier findings indicating that apoptotic function is 
reduced in humans relative to other primates and with the hypothesis that selection for 




Among the many well-documented phenotypic differences that exist between humans 
and chimpanzees is the exceptionally large size of the human brain with certain areas of 
specialized function (Carroll 2005; de Sousa and Wood 2007) and an increased incidence 
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of cancer among humans (Seibold 1973). The human brain is approximately three times 
as large as the chimpanzee brain, and epithelial neoplasms have been shown to be 
responsible for more than 20% of human deaths, compared to less than 2% in 
chimpanzees (Seibold 1973).  We previously reported the results of gene expression and 
pathway data analyses indicating that humans and chimpanzees harbor significant 
differences in apoptotic function and that this difference might help explain both the 
relatively larger size of the human brain and the increased propensity of humans to 
develop cancer (Arora et al. 2009).  
 
During neuronal development, apoptosis functions by adjusting the initial pool of 
neuronal progenitor cells for the proper morphogenesis of the nervous system. In a 
number of knockout studies conducted with mice, it has been shown that key pro-
apoptotic factors, such as Apaf1 (Honarpour et al. 2001), caspase-9 (Joza et al. 2001) and 
caspase-3 (Kuida et al. 1996), play important roles in the development of the brain.  
In addition, elevated levels of apoptotic pathway genes have been associated with several 
human neurodegenerative diseases. For example, in both Parkinson’s and Huntington’s 
diseases, apoptotic genes have been shown to be significantly up-regulated (Tatton et al. 
2003; Ferreira et al. 2010). Consistent with this observation, the pro-apoptotic factors 
caspase-1 and capsase-3 are significantly over-expressed in transgenic mouse models of 
Huntington’s disease (Chen et al. 2000).  These and other data implicating apoptosis in 
brain development suggest that the process may have been involved in human brain 
evolution as well. Indeed, comparative sequence analyses of apoptotic pathway genes 
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among primates suggest that the evolution of apoptotic genes has been accelerated within 
the human lineage relative to the other primates (Vallender and Lahn 2006).  
Cancer, in contrast, is an example of a disease where the apoptotic pathway is typically 
suppressed resulting in over-proliferation and/or reduced destruction of tumor cells (Kerr 
et al. 1972). Indeed, reduced apoptotic function is now generally considered one of the 
hallmarks of cancer (Hanahan and Weinberg 2000). 
 
Based on the above facts and our previous findings suggesting that apoptotic function 
may be reduced in humans relative to chimpanzees, we hypothesized that the selective 
pressure to increase cognitive functions/brain size in humans may have resulted in a 
reduced apoptotic function, having the indirect consequence of increasing the propensity 
of humans to develop cancer relative to chimpanzees (Arora et al. 2009).  A keystone of 
this hypothesis is the assertion that apoptotic function is significantly reduced in humans 
relative to chimpanzees. While our analysis of gene expression differences between 
chimpanzees and humans is consistent with this assertion, we sought to acquire direct 
experimental support by monitoring relative apoptotic function in human, chimpanzee 
and macaque (out group) cell lines. The results are consistent with the assertion that 
apoptotic function is indeed reduced in humans relative to chimpanzees and macaques, 
and with the hypothesis that selection for increased cognitive ability within the human 







Selection of Cell lines 
A number of previously published comparative studies between humans and non-human 
primates have successfully employed primary fibroblasts to study the differences between 
humans and non-human primates (e.g., gorilla and bonobo) (e.g., Karaman et al. 2003; 
Calarco et al. 2007). These previous studies have found that these fibroblastic cell lines 
display general molecular properties characteristic of the species. Thus, we chose to take 
a similar approach and conduct tests on primary fibroblast cell lines derived from 
humans, chimpanzees and macaques to determine relative apoptotic function among 
these species. 
 
As an initial test of the suitability of using primary fibroblast cell lines to reflect 
differences in apoptotic function between these species, we compared the expression 
levels of apoptotic pathway genes that we previously reported to differ between human 
and chimpanzee tissues by gene expression analysis (Arora et al. 2009) with previously 
reported expression differences between primate fibroblast cell lines. While gene 
expression data derived from human fibroblast cells lines is available, gene expression 
profiling of chimpanzee fibroblast cells lines is not. However, such data is available for 
bonobo fibroblast cell lines. Bonobo (Pan paniscus) is a closely related species to 
chimpanzees (Pan troglodytes) and together they make up the genus Pan (Kaessmann et 
al. 1999). The two species are genetically nearly identical (99.4%). Thus, consistent with 
accepted standards in the field (e.g., Karaman et al. 2003), we considered the gene 
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expression patterns of the bonobo cell line to be representative of chimpanzee for the 
purpose of our initial analysis.  
 
We compared the expression pattern of the 37 apoptotic genes that we previously 
identified as being differentially expressed between human and chimpanzee brains (Arora 
et al. 2009) (Table 3.1). Among the 21 genes identified as inducers of apoptosis in the 
brain dataset, 4 (19%) were not found to be expressed in the fibroblast dataset. Of the 
remaining 17, twelve genes in the fibroblast dataset (70%) displayed the same pattern of 
differential expression between human and chimpanzee/bonobo as those in the brain. 
Among the 16 genes identified as repressors of apoptosis in the brain dataset, one (6%) 
was not expressed in the fibroblasts while eight genes in the fibroblast dataset 
(53%) displayed the same pattern of differential expression as those in the brain. With 
respect to the patterns of expression of the known inducers and repressors of apoptotic 
function, there is an overall significant correlation between the brain dataset and the 
fibroblast dataset (Signs Test, p-value = 0.013). This correlation indicates that fibroblasts 














Table 3.1: Comparison of the human-chimpanzee brain dataset with the human-
bonobo/gorilla fibroblast data set with respect to the expression patterns of the 
apoptotic genes. With respect to the expression pattern of apoptotic genes, the human 
brain dataset (Arora et al. 2009)  (relative to chimpanzees) is comparable to the human 
fibroblast dataset (Karaman et al. 2003) (relative to bonobos and gorillas) (Sign’s test, p-
value=0.013). 
Gene Symbol Expression Pattern in 
human brain dataset 
relative to chimpanzees 
Expression Pattern in 
human fibroblast dataset 
relative to bonobos and 
gorillas 
INDUCERS   
1.AIFM1 Down Down 
2.BID Up Down 
3.CAPN2 Down Down 
4.CAPN3 Down Down 
5.CAPN5 Down Down 
6.CAPN7 Down Not detected 
7.CASP2       Down Down 
8.CASP6 Down Not detected 
9.CASP9 Down Down 
10.CYCS Down Down 
11.DIABLO Down Not Detected 
12.HTRA2 Down Up 
13.MKK7 Down Down 
14.ASK1 Up Up 
15.MAP4K4 Up Down 
16.ERK1 Down  Up 
17.ERK2 Down Down 
18.JNK1 Up Down 
19.R-RAS Down Up 
20.PRKCE Down Not detected 
21.SPTAN1 Down Down 
   
REPRESSORS   
22.IAP Up Up 
23.IKKA Up Up 
24.DDR1 Up Down 
25.DDR2 Up Up 
26.ICAD Down Down 
27.FGFR2 Up Down 
28.KRAS Up Down 
29.MEK2 Up Up 




Table 3.1 continued 
31.NF&B Down Down 
32. TEK Up Up 
33.EGFR Up Up 
34.IKBKB Down Down 
35.PARP1 Down Down 
36.TYRO3 Down Up 
37.PDGFRA Down  Up 
 
Human cells display higher cell viability than chimpanzee and macaque cells after  
treatment with apoptotic-inducing agents 
To test for differences in cell viability between the human (AG13153), chimpanzee 
(S006007) and macaque (AG07915) cells after induction of apoptosis, cells were treated 
with the apoptotic-inducing agents staurosporine and mitomycin C (MMC). After 
treatment, differences in cell viability between the different species were measured using 
a cell viability assay. 
 
Staurosporine is a natural product isolated from Streptomyces staurosporeus. It induces 
apoptosis by inhibiting protein kinase C, a known inducer of the anti-apoptotic Bcl-2 
(Deng et al. 2000). MMC is a natural product isolated from Streptomyces caespitosus  
(Szybalski and Iyer 1964) and is a known chemotherapeutic agent used in the treatment 
of a number of cancers (Tomasz 1995). MMC is a DNA cross-linking agent and damages 
DNA by cross-linking bases in the same or adjacent strands of DNA. This cross-linking 
eventually triggers a powerful apoptotic stimulus, including the activation of p53 (Seong 
et al. 2005). 
 
Cell lines derived from each species were treated with MMC, in a dose dependent 
manner, and cell viability was measured 72 hours after treatment using the Cell Titer 
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Blue assay in a 96 well plate. The experiment was replicated 4 times. Treating the cells 
with MMC significantly reduced viability of the chimpanzee (S006007) and macaque 
(AG07915) cells at relatively low doses of the drug, while the human cells (AG13153) 
displayed reduced viability only at higher concentrations of the drug (50 µM)  (Figure 
3.1).  Relative cell viability in the chimpanzee cells were reduced from 112% (0.01 µM) 
to 52% (1 µM), followed by a steady decrease for the subsequent doses with a cell 
viability of 32% at the highest dose (150 µM) of the drug. In the case of the macaque 
cells, relative cell viability was reduced from 87% (0.01 µM) to 58% (1 µM), followed 
by another drop to 15% (50 µM), which steadily dropped to 4% at the highest dose (150 
µM) of the drug. 
 
In the case of the human cells, cell viability decreased from 98% (0.01 µM) to 56% (50 
µM), decreasing to 37% at the highest dose (150 µM) of the drug. The relative cell 
viability differences between the human and the chimpanzees were significant (student’s 
t-test, p<0.05) at 1 µM, 5 µM, 10 µM and 50 µM of the MMC. Likewise, differences 
between the humans and the macaques were significant at all doses of the drug, except 
0.01 µM of MMC. In all cases, cell viability was higher in the humans compared to 







Figure 3.1:  Relative viability of human (AG13153), chimpanzee (S006007) and 
macaque (AG07915) cells after treatment with mitomycin C (MMC). Cells were 
treated with different doses (0.1 µM – 150 µM) of the drug MMC for 72 hrs, after which 
cell viability was measured using the Cell Titer Blue assay. Each data point represents the 
mean of four replicates ± SD. Cell viability was expressed as a percentage of the viable 
cells in the treated group to the untreated control group (0 µM). The difference in cell 
viability was significant between humans and chimpanzees at 1 µM, 5 µM, 10 µM and 50 
µM of MMC (student’s t-test, p<0.05), and between humans and macaques at all doses 




Similar results were seen when the human (AG13153) and chimpanzee (S006007) cells 
were treated with staurosporine (Figure 3.2), with the humans cells being more viable 





Figure 3.2: Relative cell viability between human (AG13153) and chimpanzee 
(S006007) cells after treatment with staurosporine. Cells were treated with different 
doses (0-500 nM) of the drug staurosporine for 48 hrs, after which cell viability was 
measured using the Cell Titer Blue assay. Each data point represents the mean ± SD of 
four replicates. Cell viability was expressed as a percentage of the viable cells in the 
treated group to the untreated control group (0 µM). The difference in cell viability was 





Human cells treated with the apoptotic-inducing agent mitomycin C (MMC), 
display significantly higher IC50 values than chimpanzee or macaque cells 
IC50 (half maximal inhibitory concentration) is a measure of the effectiveness of a 
compound or a drug to inhibit a biological function (e.g., cell viability) by 50% (Cheng 
and Prusoff 1973). The IC50 values of MMC were computed and compared between 
human (AG13153), chimpanzee (S006007) and macaque (AG07915) cell lines. The 
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results presented in Table 3.2, show that the MMC IC50 values are significantly higher 
(student’s t-test, p<0.05) for the human cells than either chimpanzees or macaques, 
consistent with the hypothesis that human cells have reduced apoptotic function. The IC50 
values in the chimpanzee and the macaque cell lines were 10.72 µM and 6.04 µM 




Table 3.2: Relative IC50 values after treatment of human (AG13153), chimpanzee 
(S006007) and macaque (AG07915) cells with mitomycin C (MMC).  The difference 
in the IC50 values between the humans and chimpanzees and between the human and 
macaques in both sets was significant (student’s t-test, p<0.05) 
 
Cell Line IC50 
Human (AG13153) 78.87  µM 
Chimpanzee (S006007) 10.72 µM 




Human cells display phenotypic features characteristic of reduced apoptotic 
function relative to chimpanzee cells after treatment with the apoptotic-inducing 
agent mitomycin C (MMC) 
Cells were treated with different doses of MMC (10!M, 15!M and 100!M), washed with 
PBS and stained with 10 µg/ml of Hoechst dye for 15 minutes. The cells were then 




The nuclei of the control cells had an oval shape with homogeneous intensity (Figure 
3.3A), whereas cells treated with MMC typically displayed phenotypic features that are 
characteristic of apoptosis including condensed and fragmented shapes with irregular 
staining homogeneity (Ziegler and Groscurth 2004). The phenotypic characteristics of the 
two human cell lines  (AG13153 and AG07307) treated with 10 µM (Figure 3.3B) and 
15µM (Figure 3.3E) of MMC respectively were similar to those of the control cells 
(Figure 3.3A). At a higher dose of MMC (100 µM), one human cell line (AG13153) 
showed phenotypic characteristics of apoptosis (Figure 3.3H).  
 
The chimpanzee cells (S006007 and S005795) treated with 10 µM (Figure 3.3C) and 15 
µM (Figure 3.3F) of MMC respectively showed DNA condensation and fragmentation 
consistent with onset of apoptosis. Likewise, there were similar results for the 
chimpanzee cells (S006007) treated with 100 µM of MMC (Figure 3.3I). Similar results 
were seen for the macaque cells (AG07915 and AG07128) treated with 10 µM (Figure 
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Figure 3.3: Human cells display morphological features characteristic of reduced 
apoptotic function relative to chimpanzee and macaque cells after treatment with 
mitomycin C (MMC). Cells were treated with the indicated concentration of MMC and 
then stained with 10 µg/ml of Hoechst and visualized under the fluorescence microscope. 
A) Chimpanzee cells (S006007) used as control; B) Human cells (AG13153) treated with 
10 µM of MMC; C) Chimpanzee cells (S006007) treated with 10 µM of MMC; D) 
Macaque cells (AG07915) treated with 10 µM of MMC; E) Human cells (AG07307) 
treated with 15 µM of MMC; F) Chimpanzee cells (S005795) treated with 15 µM of 
MMC; G) Macaque cells (AG07128) treated with 15 µM of MMC; H) Human cells 
(AG13153) treated with 100 µM of MMC and I) Chimpanzee cells (S006007) treated 
with 100 µM of MMC. White arrows in the picture indicate cells showing phenotypic 
characteristics of apoptosis, such as DNA fragmentation (Figures 3.3C, D, F, G and H). 
The control (Figure 3.3A) showed normal phenotypic characteristics without any 
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Human cells display lower caspase-3/7 activity than chimpanzee cells after 
treatment with staurosporine 
The executioner caspase-3/7 is activated during apoptosis and is considered a biomarker 
of the process (Elmore 2007). Thus, the activity of these caspases was compared between 
human (AG13153) and chimpanzee (S006007) cells after treatment with increasing doses 
(100 nM and 300 nM) of the apoptotic-inducing drug staurosporine using the Caspase-3/7 
Glo Assay (Liu et al. 2004). For both doses of the drug, the chimpanzee cells displayed 
significantly (student’s t-test, p<0.05) higher caspase-3/7 activity than the human cells 













Figure 3.4: Human (AG13153) cells display lower caspase-3/7 activity than 
chimpanzee cells (S006007) after treatment with staurosporine.  
Chimpanzee cells displayed significantly higher caspase-3/7 activity than human cells at 
100 nM of staurosporine (student’s t-test, p=0.023) and at 300 nM of staurosporine 





Human cells display reduced release of apoptotic factors relative to chimpanzee cells 
after treatment with the apoptotic-inducing drug mitomycin C (MMC) 
The apoptotic pathway consists of the extrinsic and the intrinsic pathways (Elmore 2007), 
both of which converge on activating the executioner caspases, caspase-3 and caspase-7 
(Tait and Green 2010). The intrinsic pathway proceeds through the release of pro-
apoptotic factors (cytochrome C, Diablo and AIF) present in the mitochondrial 
intermembrane space, which then leads to the activation of apoptosis. This release of pro-
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apoptotic factors occurs due to the permeabilization of the inner and outer mitochondrial 
membranes (Kroemer and Reed 2000). 
 
Under normal physiological conditions, a transmembrane electrical potential gradient     
(!"m) is maintained across the mitochondrial membranes, and this gradient is indicative 
of the normal functioning of the mitochondria (Mitchell 1961). On the induction of 
apoptosis, the mitochondrial outer membrane permeabilizes, resulting in the release of 
pro-apoptotic factors as well as a reduction of !"m (Budd et al. 2000). Reduction of !"m 
is indicative of apoptosis and can be easily measured using lipophilic, cationic 
fluorescent redistribution dyes, such as tetramethyl rhodamine ethyl (TMRE) and methyl 
(TMRM) (Ehrenberg et al. 1988). 
 
In healthy, non-apoptotic cells, these lipophilic dyes bearing a delocalized positive charge 
enter the negatively charged mitochondria and fluoresce at a certain intensity. On the 
induction of apoptosis, as !"m is disrupted, these dyes no longer accumulate in the 
mitochondria and become dispersed in the cytosol, resulting in an overall drop in the 
level of cellular fluorescence (Rasola and Geuna 2001). This drop in fluorescence is 
indicative of apoptosis. Using flow cytometry, the number of cells undergoing this drop 
in fluorescence can be measured.  
 
These dyes were used to test whether the number of apoptotic cells differed between 
humans and chimpanzees cell lines once apoptosis was induced. The human (AG07307) 
and chimpanzee (S005795) cell lines were treated with 30 µM and 100 µM of MMC. 
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After 72 hours, the cells were treated with 100 nM of TMRE dye, and then the amount of 
apoptotic cells was measured in the two samples. 
 
The chimpanzee cells, following treatment with 30 µM of MMC, had approximately 
69.1% (average of two replicates) apoptotic cells, whereas the human cells treated with 
the same dose had approximately 33.8% apoptotic cells (Table 3.3 and Figure 3.5A). 
Similarly, the chimpanzee cells treated with 100 µM of MMC had 72.9% apoptotic cells, 
compared to the human cells, which had 42.8% apoptotic cells (Table 3.3 and Figure 
3.5B). The difference in the number of apoptotic cells between the two samples was 




Table 3.3: Number of human (AG07307) and chimpanzee (S005795) cells 
undergoing apoptosis, expressed as a percentage of the total number of cells 
detected by flow cytometry, when treated with 30 and 100 !M of mitomycin C 
(MMC). Human (AG07307) and chimpanzee (S005795) cells were treated with 30 !M 
and 100 !M of the apoptosis-inducing agent mitomycin C for 72 hours. Subsequent to 
treatment for 72 hours, the percentage of viable cells remaining was monitored by flow 
cytometry using fluorescence the lipophilic dyes, tetramethyl rhodamine ethyl (TMRE) 
and methyl (TMRM). The results indicate that human cells are significantly (proportions 
test, p<0.05) more resistant to treatment by mitomycin C than chimpanzee cells reflecting 
reduced apoptotic function. 
 
 Untreated 30 µM MMC 100 µM MMC 
36.6% Human 5.15% 
30.9% 
42.8% 








   
 
Figure 3.5: Mitochondrial membrane potential (!"m) is reduced to a lesser extent 
in human cells (AG07307), relative to chimpanzee cells (S005795) when treated with 
A) 30 !M and B) 100 !M of mitomycin C (MMC). Human and chimpanzee cells were 
treated with different doses of MMC, and mitochondrial membrane potential was 
detected by monitoring relative levels the fluorescence of lipophilic dyes, tetramethyl 
rhodamine ethyl (TMRE) and methyl (TMRM). A reduction in fluorescence is indicative 
of onset of apoptosis. The results indicate that chimpanzee cells are associated with 
higher apoptotic function than human cells (Red lines = untreated cells; Blue lines = cells 
treated with the indicated levels of MMC). Mitochondrial membrane potential was 
monitored by measuring fluorescence at 574 nm (FL-2), as represented by the x-axis, 







Among the documented differences between humans and chimpanzees are the relative 
large size of the human brain with certain areas of specialized function and the 
susceptibility of humans to diseases like cancer. Since apoptosis plays a role in both the 
development of the brain and disease progression to cancer, it is plausible that these 
differences may be attributed to differences in apoptotic function. Previous comparative 
gene expression analyses from our lab suggested that humans may have a reduced 
apoptotic function compared to chimpanzees (Arora et al. 2009).  
 
In an effort to directly test the hypothesis of a reduced apoptotic function in humans, 
human and chimpanzee cells were treated with known apoptotic-inducing agents and the 
relative response of the cells monitored. A variety of tests were conducted and the results 
were uniformly consistent with the hypothesis that the apoptotic function in humans is 
reduced compared to chimpanzees. For example, at low doses of the apoptotic agent 
MMC (10 µM and 15 µM), chimpanzee cells displayed a lower number of viable cells 
(Figure 3.1) compared to the human samples. The phenotypic characteristics of the 
chimpanzee cells at these doses were typical of apoptosis showing nuclear condensation 
and DNA fragmentation (Figure 3.3C and 3.3F). In contrast, the phenotypic 
characteristics of the human cells at these low doses (Figure 3.3B and 3.3E) were similar 
to the control or untreated cells (Figure 3.3A), indicating that very little or no apoptosis 
was occurring in the human samples, as also indicated by higher cell viability in human 
cells. The comparison of the IC50 values of MMC in the human and chimpanzee cells 
confirmed that the chimpanzee cells were more sensitive to MMC induced apoptosis 
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(Table 3.2). These and the other results are consistent with the hypothesis that humans are 
associated with reduced apoptotic function relative to chimpanzees. 
  
To determine whether the observed differences in apoptotic function between humans 
and chimpanzees was most likely to have occurred in the human or chimpanzee lineage, 
we used macaque as an out-group in our assays. The results consistently indicated that 
macaque cells behaved like chimpanzee cells in displaying higher sensitivity to apoptotic 
inducing agents relative to human cells.  These findings are consistent with the 
hypothesis that the reduced apoptotic function associated with human cells is an 
evolutionarily derived condition occurring within the human lineage subsequent to the 
divergence of humans and chimps from a common ancestor ' 6 MYA (Goodman 1996).  
 
Previous studies have demonstrated that apoptosis plays a significant role in mammalian 
neuronal development (Kuida et al. 1998; Honarpour et al. 2001; Joza et al. 2001). Thus, 
it is possible that selection for increased cognitive ability in humans may have involved 
changes in the apoptotic pathway. Consistent with this possibility is previously published 
findings indicating that apoptotic genes display accelerated rates of evolutionary change 
within the human lineage relative to the other primates (Vallender and Lahn 2006). Our 
previous analysis of gene expression differences between chimpanzees and humans 
independently suggested that apoptotic function in the brain and other tissues may be 
significantly reduced in humans relative to chimpanzees (Arora et al. 2009). These 
differences led us to postulate that selective pressure for increased cognitive ability 
within the human lineage may have, at least in part, resulted in reduced apoptotic 
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function. Since a reduced apoptotic function is a well known hallmark of cancer, we 
further hypothesized that selection for increased cognitive ability may have indirectly 
resulted in an increased risk of cancer in humans relative to chimpanzees. Since the onset 
of most cancers occurs well beyond reproductive age, there may have been little or no 
negative consequence of the reducing apoptotic function to increase brain size within the 
human lineage.  
 
Like many evolutionary hypotheses, this model cannot be definitively substantiated. 
However, there is growing evidence that the propensity of many medical conditions in 
humans can be linked with traits or functions that were adaptive within our evolutionary 
past (Nesse et al. 2010). The results of the molecular studies reported here substantiate 
our earlier gene expression analyses indicating that apoptotic function is significantly 
reduced in humans relative to chimpanzees. These findings coupled with earlier studies 
linking apoptotic function with neural development and cancer, are consistent with the 
hypothesis that the evolution of increased cognitive function in humans may have 




Fibroblast Cell Lines and Reagents 
Primary human, chimpanzee and macaque fibroblast cell lines were obtained from Coriell 
cell repositories (Camden, NJ, USA) after they were matched for age and gender and 
after the generation gap between the species was taken into account (Table 3.4). All the 
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primary fibroblast cultures were initiated from explants of 2-mm-skin biopsies and 




Table 3.4: Fibroblast cell lines used in the experiments 
 
Human Chimpanzee Macaque 
AG13153 (30 year old 
Male) 
S006007 (22 year old Male) AG07915 (12 year old 
Male) 
AG07307 (40 year old 
female 
S005795 (26 year old 
female) 





Mitomycin C was obtained from Sigma Aldrich, MO, USA, and staurosporine from 
Fisher Scientific, PA, USA. 
 
Cell Culture 
Primary fibroblasts were cultured in a rich medium (DMEM supplemented with 
essential/non essential amino acids, vitamins, antibiotics and 10%FBS) at 37°C in 5% 
CO2. The growth rates for each of the cell lines were determined in 96 well plates using 
the Cell Titer Blue (Promega Corporation, WI, USA) cell viability assay. Passage 
numbers at which tests were done were as follows: human (AG13153) P14-P16; 
chimpanzee (S006007) P14-P16; macaque (AG07915) P16-P18; human (AG07307) P17-





Cell Viability Assay 
The cell viability experiments were conducted in 96 well plates. The number of cells 
seeded per well was determined from the growth curves and was 80,000 cells/ml for the 
human cell lines, 120,000 cells/ml for the chimpanzee cell lines and 60,000 cells/ml for 
the macaque cell lines. The cells were allowed to grow for 24 hours, after which some of 
them were treated with different doses of staurosporine and MMC for 48 and 72 hours 
respectively. Some were untreated controls. The dilutions for the drugs were done by 
using the stock solution of the drug and then diluting it with RPMI + 5% FBS media.  
 
After treatment with the drugs, the cells were treated with 20 µl of Cell Titer Blue reagent 
(Promega Corporation, WI, USA), followed by incubation at 37°C for two hours. The 
fluorescence was then measured in the range of 560EX/590EM in a fluorescence plate 
reader (Bio-Tek Multi detection microplate reader, Bio-Tek, VT, USA). The values 
obtained for both treated and untreated samples were averaged for each dose of the drug, 
and then cell viability was calculated as per manufacturer’s instructions (Promega 
Corporation, WI, USA). 
 
Hoechst Staining 
The cells in the 96 well plates were washed twice with 100 µl of PBS, followed by 
staining with 10 µg/ml of Hoechst dye for 15 minutes. The cells were then visualized 
using a microscope (Olympus IX51, Olympus, NJ, USA) and photographed using an 
Olympus DP72 digital camera. 
 
 71 
Caspase-3/7 Activity Assay 
The human (AG13153) and chimpanzee (S006007) cells in the 96 well plates were 
allowed to grow for 24 hours, followed by treatment with staurosporine for 48 hours to 
induce apoptosis. Following treatment with the drug, 100 µl of the Caspase-3/7 Glo 
reagent (Promega Corporation, WI, USA) was added, followed by incubation at 37°C for 
30 minutes to generate a luminescence signal. The caspase-3/7 activities were determined 
by monitoring the activity on a luminescence plate reader (Spectramax Gemini XS 
Microplate Spectrofluorometer, Molecular Devices, CA, USA). 
 
Measurement of Mitochondrial Transmembrane Potential 
Changes in !"m were detected using tetramethyl-rhodamine ethyl (TMRE) or methyl 
(TMRM). Human (AG07307) and chimpanzee (S005795) cells were grown in 10 ml 
Petri dishes for 24 hours, after which they were treated with different doses of MMC for 
72 hours. Trypsinized cells were combined with the supernatant medium and incubated 
with 100 nM of TMRE/TMRM for 30 minutes in the dark at 37°C. TMRE fluorescence 
was measured using the FL2 (574 nm) of the BD LSR II flow cytometer. Analysis of the 
data was done using Flo Jo 7.6 software. 
 
Statistical Analysis 
To analyze the differences in cell viability and caspase-3/7 activities, a student’s t-test 
was performed in Excel. The proportions test, done in R, was used to analyze differences 
in the number of apoptotic cells between humans and chimpanzees. Mean differences 
were considered to be significant when p<0.05. 
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Analyses of IC50 values were computed from concentration-response curves using 
GraphPad Prism 5.0 (Graph Pad software, San Diego CA, USA). 
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CHAPTER 4 
INDEL VARIATION BETWEEN HUMANS AND CHIMPANZEES IS 




Although humans and chimpanzees have accumulated significant differences in a number 
of phenotypic traits since diverging from a common ancestor about six million years ago, 
their genomes are >98.5% identical at the protein coding loci. This modest degree of 
nucleotide divergence is not sufficient to explain the extensive phenotypic differences 
between the two species. It has been hypothesized that the genetic basis of the phenotypic 
differences lies at the level of gene regulation, which is possibly associated with the 
extensive INDEL (insertion/deletion) variation between the two species. 
To test the hypothesis that large INDELs (80-12,000 bp) may have contributed 
significantly to differences in gene regulation between the two species, we have 
categorized human-chimpanzee INDEL variation mapping in or around genes and 




                                                
* This chapter reports on a collaborative study, in which my contribution focused on the 
gene expression differences. 
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Results 
We found that there is a significant correlation between differences in gene expression 
and INDEL variation between chimpanzees and humans predominantly involving the 
insertion of interspersed (predominantly retrotransposon) and non-interspersed sequences 
in the human lineage. The majority of this functionally significant INDEL variation was 
mapped to introns and arose in the human lineage after humans and chimpanzees 
diverged from a common ancestor. 
Conclusion 
Our results are consistent with the hypothesis that INDELs have played a significant role 
in human/chimpanzee evolution. Most of the differential gene expression seen between 




Although humans and chimpanzees have accumulated significant differences in a number 
of phenotypic traits since diverging from a common ancestor about six million years ago, 
their genomes are >98.5% identical at the protein coding loci (Mikkelsen et al. 2005). 
This modest degree of nucleotide divergence does not seem sufficient to explain the 
extensive phenotypic differences between the two species, and it has been hypothesized 
that the genetic basis of the differences lies at the level of gene regulation (King and 
Wilson 1975), which is possibly associated with the extensive insertion/deletion (INDEL) 
variation existing between the two species (Britten 2002).  
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A number of comparative genomic studies carried out between humans and non-human 
primates have revealed that significant INDEL variation exists between these species 
(Frazer et al. 2003; Watanabe et al. 2004; Chen et al. 2007a; Chen et al. 2007b). In one of 
the first studies done to identify human and chimpanzee INDEL variation, a 27 Mb 
region of the human chromosome 21 was compared with chimpanzee DNA sequences, 
and approximately 57 INDELs were identified (Frazer et al. 2003). In another study 
comparing the human chromosome 21 with the syntenic chimpanzee chromosome 22, as 
many as 68,000 INDELs were identified (Watanabe et al. 2004). In a recent comparison 
of human chromosome 21 and chimpanzee chromosome 22, as many as 6279 INDELs of 
size >10 bp were identified (Volfovsky et al. 2009). 
 
We have previously shown that interspersed repeats, particularly retrotransposons, have 
contributed significantly to the INDEL variation between humans and chimpanzees 
(Polavarapu et al. 2006). Similarly, in another study done to classify recently inserted 
retrotransposons between humans and chimpanzees, it was shown that humans have a 
greater rate of insertions compared to chimpanzees, and the majority of these insertions 
are Alu elements and is located in or around genes (Mills et al. 2006b). Since 
retrotransposon sequences located in or around genes have the capacity to significantly 
alter patterns of gene expression, it has long been recognized that these sequences may be 




Another source of INDEL variation between humans and chimpanzees is simple tandem 
repeats (Tautz et al. 1986; Du et al. 1997). It has been proposed that tandem repeats 
located in or around genes alter gene expression by interacting with transcription factors, 
by altering chromatin structure or by acting as potential protein binding sites (Hamada et 
al. 1984; Pardue et al. 1987; Yee et al. 1991). Since tandem repeats in or around genes 
are capable of altering gene expression, they have also been postulated to play a role in 
regulatory evolution (Pardue et al. 1987; Sinha and Siggia 2005; Tomilin 2008), e.g., it 
was shown that variation associated with tandem repeats in the regulatory region of the 
vasopressin 1a receptor gene may account for the differences in social behavior between 
humans and chimpanzees (Hammock and Young 2005). 
 
In this study, we present a detailed characterization of large INDEL variation (80-12,000  
bp in length) associated with human and chimpanzee genes and test if this variation is 
significantly correlated with differences in gene expression in a variety of tissues. Our 
results indicate that both interspersed repeats (predominantly retrotransposons) and non-
interspersed sequences, mapping to introns, have contributed significantly to 










Characterization of human and chimpanzee gaps 
We use the terms “human gaps” (HGs) to refer to sequences present in chimpanzees but 
absent in humans and “chimpanzee gaps” (CGs) to sequences present in humans but 
absent in chimpanzees (Polavarapu et al. 2006). Collectively, these gaps constitute the 
INDEL variation between humans and chimpanzees. Using the database available at the 
UCSC Genome Bioinformatics web site (Kent et al. 2002), a total of 11365 HGs and 
15144 CGs were identified (Table 4.1). The majority of these gaps (63 % of HGs and 
75% of CGs) are associated with interspersed repeats, i.e. sequences that are repeated 
multiple times throughout the genome, and nearly all of these (>99%) are homologous to 
retrotransposon sequences (REs). Of the remaining gaps (37% of HGs and 25% of CGs), 
comprised of non-interspersed sequences (NISs), 33% are made up of tandem repeats and 
67% are small INDELs of unique sequence (Table 4.1).  
 
The presence of a sequence in humans (or vice versa in chimpanzees) that is missing at 
an orthologous genomic position in chimpanzees (humans) can either be due to an 
insertion in one species or a deletion in the other. By using macaques (Macaca mulatta) 
as an out-group (Figure 4.1), it was determined that the majority of the INDEL variation 
between humans and chimpanzees is due to insertions. For example, 57% of the 
retrotransposon-associated human INDELs are the result of chimpanzee insertions (CIs), 
and 43% are the result of human deletions (HDs), while 76% of the retrotransposon-
associated chimpanzee INDELs are due to human insertions (HIs), and 24% are due to 
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chimpanzee deletions (CDs) (Table 4.2a). While the majority of non-interspersed 
sequences associated with tandem repeats (57% of the human INDELs and 61% of the 
chimpanzee INDELs) are insertions, the majority of the unique non-interspersed 
sequences (60% of the human INDELs and 53% of the chimpanzee INDELs) are due to 




Table 4.1: Number of INDELs associated with different categories of sequences. 
Human (HGs) and chimpanzee gaps (CGs) constitute the INDEL variation between the 
two species. The INDELs contain interspersed repeats and non-interspersed sequences. 
Interspersed repeats are transposable element sequences that are present multiple times 
throughout the genome. The majority of interspersed repeats are retrotransposon 
sequences (sub categories: SINEs, LINEs, ERVs, SVAs and MEs. See text for further 
characterization). DNA transposable elements constitute <1% of interspersed repeats. 
Non-interspersed sequences (NISs) are tandem repeats or unique sequences that map to 
specific (INDEL) sites in the genome. 
 




Total number of gaps 11365 15144 
Interspersed Repeats (all) 7176 11398 
Interspersed sequences (retrotransposons) 7121 11355 
 Retrotransposons  (SINEs) 3494 7021 
 Retrotransposons (LINEs) 1847 2052 
Retrotranspsons (ERVs) 519 356 
Retrotransposons (SVAs) 114 681 
Retrotransposons (MEs) 1147 1245 
Interspersed sequences (DNA elements) 55 43 
Non-interspersed sequences (all) 4189 3746 
Non-interspersed sequences (tandem 
repeats) 
1266 1334 









Table 4.2: Number of human and chimpanzee INDELs associated with  
a) retrotransposons and b) non-interspersed sequences. Using macaque as an out-
group, INDEL variation was characterized as chimpanzee insertions (CIs), human 




 Human INDELs Chimpanzee INDELs 
Retrotransposon subclass CIs HDs CIs + HDs HIs CDs HIs + CDs 
SINE 2264 1230 3494 5787 1234 7021 
LINE 1311 536 1847 1756 296 2052 
ERV 208 311 519 156 200 356 
SVA 98 16 114 680 1 681 
ME 154 993 1147 269 976 1245 




 Human INDELs Chimpanzee INDELs 
Non-interspersed 
sequence subclass 
CIs HDs CIs + HDs HIs CDs HIs + CDs 
Tandem repeats 720 546 1266 814 520 1334 
Unique sequences 1156 1767 2923 1145 1267 2412 

















































Figure 4.1: Method of characterizing INDELs as insertions or deletions in the 
chimpanzee or human lineage. (a) A region of the chimpanzee chromosome (green) 
showing a gap when it is aligned against a homologous region of the human chromosome 
(blue). The sequence corresponding to the gap region in the chimpanzee chromosome is 
found in the macaque (out-group) chromosome (red). The presence of the sequence in 
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chromosome characterizes the gap as a chimpanzee deletion (CD); analogous reasoning 
was used to identify (b) human insertions (HIs); (c) human deletions (HDs) and (d) 




Analysis of interspersed repeats homologous to retrotransposon sequences  
As mentioned above, nearly all of the interspersed repeats associated with HGs and CGs 
(~99%) are homologous to retrotransposon sequences (REs). The REs were grouped into 
five different classes: 1) SINEs (short interspersed nuclear elements), 2) LINEs (long 
interspersed nuclear elements), 3) ERVs (endogenous retroviruses), 4) SVAs 
(biologically active composite elements consisting of fragments of SINEs, VNTRs 
(variable number of tandem repeats), and Alu elements) and 5) MEs (mosaic elements, 
which are inactive sequences comprised of a mosaic of more than one class of the above 
retrotransposon homologous sequences). Of the REs associated with HGs, 49 % are 
homologous to SINEs, 26% to LINEs, 7% to ERVs, 2% to SVAs and 16% to MEs (Table 
4.1). Of the REs associated with CGs, 62% are homologous to SINEs, 18% to LINEs, 3% 
to ERVs, 6% to SVA and 11% to MEs (Table 4.1). These values are proportional to the 
relative frequency of the various classes of retrotransposons in the human and 
chimpanzee genomes (Lander et al. 2001; Mikkelsen et al. 2005). 
 
Consistent with the relative transpositional activity of retrotransposon families in humans 
and chimpanzees (Lander et al. 2001; Mikkelsen et al. 2005), it was seen that the majority 
of the insertions involve SINEs and LINEs (Table 4.2a). The frequency of ERV 
insertions is 1.3 fold higher in chimpanzees than in humans, predominantly due to the 
expansion of two chimpanzee-specific ERV families (CERV 1/PTERV1 and CERV 2) 3-
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5 million years ago (Yohn et al. 2005; Maksakova et al. 2006; Polavarapu et al. 2006). In 
contrast, the frequency of SVA insertions in humans is > 6-fold higher than in 
chimpanzees (Table 4.2a). The overall frequency of REs insertions is >2 fold higher in 
humans than in chimpanzees. The frequency of LINE, SVA and ERV deletions is higher 
in humans than in chimpanzees, while the frequency of SINE and ME deletions are 
nearly the same in both species (Table 4.2a).  
 
Lineage specific interspersed (retrotransposon) insertions are responsible for the 
majority of INDELs located in or around human and chimpanzee genes 
Of the 34,914 human/chimpanzee genes listed in the ENSEMBL database (Hubbard et al. 
2007), 10597 or 30% (10597/34,914) were found to be associated with INDELs, i.e., 
having one or more INDELs located in or within 5 kb upstream or downstream of genes 
(Table 4.3). There are 6873 genes associated with INDELs containing REs only; 2908 
genes associated with INDELs containing NISs only; and 816 INDEL-associated genes 
containing both REs and NISs. The number of genes with INDELS containing RE 
sequences (6873 + 816 = 7689) is greater than the number of genes associated with 
INDELs containing NISs (2908 + 816 = 3724). 
 
A greater number of the genes associated with INDELs containing REs were classified as 
HIs (3149 + 326 = 3475). The number of genes associated with INDELs containing NISs 
and classified as HIs (718 + 326 = 1044) was greater than the number of genes associated 
with INDELs containing NISs and classified as HDs (740 + 155 = 895). In summary, the 
majority of the human-chimpanzee INDEL variation located in or around human and 
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chimpanzee genes is due to the insertion of REs in the human lineage after divergence 




Table 4.3: Number of genes associated with INDELs. The genes associated with 
INDELs were classified depending on the type of INDEL (HIs, CIs, HDs, and CIs) 























HI 3149 718 326 4193 
CI 1276 674 175 2125 
HD 1139 740 155 2034 
CD 1309 776 160 2245 




INDEL variation is correlated with differences in gene expression 
To explore the relationship between human-chimpanzee INDEL variations and the 
differences in gene expression, a previously published human-chimpanzee expression 
dataset consisting of expression arrays from five different tissues (brain, testis heart, liver 
and kidney) (Khaitovich et al. 2005) was reanalyzed. A major goal of this previous study 
was to correlate sequence differences with expression differences, and a number of 
microarray!probe sets for which quality sequences could not be obtained in humans and 
chimpanzees (e.g., required for the calculation of ka/ki values) was excluded. Since the 
quality of the chimpanzee genome sequence has improved in recent years, and since our 
interest is in the possible contribution of INDELs to chimpanzee–human expression 




The most dramatic difference in gene expression between humans and chimpanzees was 
seen in the testis (70% of genes display a significant difference in expression between 
chimpanzees and humans), followed by heart (51%), brain (49%), kidney (47%) and liver 




Table 4.4: Number of genes differentially expressed between humans and 
chimpanzees across five tissues. The percentage in parenthesis is calculated by dividing 
the number of genes that were differentially expressed or not in each tissue by the total 
number of genes detected in that tissue. 
 
 Brain Testis Heart Liver Kidney 
Number of genes 
detected 
14133 15445 13497 13684 14059 

























As mentioned above, the majority of INDELs are homologous to REs (Table 4.3). The 
expression levels of genes associated with the various classes of REs  (SINEs, LINEs, 
ERVs, SVAs and MEs) were analyzed to determine if any particular class is 
preferentially associated with genes displaying significant differences in expression. 
Genes associated with INDELs containing SINEs were differentially expressed 
significantly between humans and chimpanzees in testis (proportions test, p=8.2E-06), 
brain (proportions test, p=8.4E-04), kidney (proportions test, p=3.05E-06), heart 
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(proportions test, p=0.001) and liver (proportions test, p=0.03). Genes associated with 
INDELs containing other classes of REs, on the other hand, were differentially expressed 
significantly in relatively fewer tissues (Table 4.5). SINEs are the most abundant and 
transpositionally active class of retrotransposons in humans and chimpanzees and have 
frequently been associated with functionally important insertion mutations in humans 




Table 4.5: Association of INDEL variation containing retrotransposon sequences 
(REs) with differential gene expression. The INDEL-associated genes were classified 
on the type of REs (SINE, LINE, ER, SVA and ME) present in the INDEL. The 
proportions test was used to associate differential gene expression between humans and 
chimpanzees with the INDEL variation by comparing the proportion of INDEL-
associated genes that were differentially expressed (DE) with the proportion of INDEL-
associated genes that were detected but not differentially expressed (Exp) between the 
two species. Genes associated with INDELs that contained SINEs showed significant (** 
p<0.01, *p<0.05) association with differential gene expression in all tissues, whereas 
genes associated with INDELs containing other type of RE sequences showed significant 
association with differential expression in relatively fewer tissues.  
 
Type of RE 
sequence 
Brain Testis Heart Liver Kidney 









1051* 1315 1365** 
LINE 415 431 259 617 362 409 456 302 421 369 
ERV 57 71 42 90 46 66 56 63* 63 63 
SVA 137 121 68 210* 111 128 155 86 131 122 




To determine more precisely the nature of the association of differential gene expression 
with INDEL variation, the differentially expressed genes were grouped into four 
categories with respect to the intra-genic location of the associated INDELs: 1) Exon, 2) 
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Upstream (within 5000 bp upstream of transcription start site), 3) Downstream (within 
5000 bp downstream of transcription termination site), and 4) Intron. In addition, the 
differentially expressed genes were also grouped with respect to the composition of the 
INDEL (REs vs. NISs).  
 
There was no significant association of differential gene expression with INDEL 
variation located in the region upstream of the transcription start site in any of the tissues 
(Table 4.6). There was association of differential gene expression with INDELs located 
in the exons in the liver only, where INDELs containing NISs were significantly 
associated with differential gene expression (proportions test, p=0.002). INDEL variation 
mapping downstream of the transcriptional termination site was seen to be significantly 
associated with differences in gene expression only in the kidney, particularly with 
INDELs containing REs (proportions test, p= 6.5E-04). In all the tissues, there was 
significant association (proportions test, p<0.05) of INDEL variation located in the 




Table 4.6: Association of INDEL variation with differential gene expression, based on the location and composition of 
the INDEL. Genes associated with INDELs were classified with respect to the intra-genic location of the INDEL (Exon, 
Upstream, Downstream and Intron) and composition of the INDEL – retrotransposon sequences (REs) vs. non-interspersed 
sequences (NISs). The proportions test was used to associate differential gene expression between humans and chimpanzees 
with INDEL variation by comparing the proportion of INDEL-associated genes that were differentially expressed (DE) with 
the proportion of INDEL-associated genes that were detected but not differentially expressed (Exp) between the two species. 
Genes associated with INDELs located in the intronic region showed significant (** p<0.01, *p<0.05) association with 
differential gene expression in all tissues, whereas genes associated with INDELs in the exon and downstream region showed 
significant association with differential expression in the liver and kidney respectively.  
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Genes differentially expressed in all tissues are preferentially associated with 
INDELs 
If the presence of an INDEL around human and chimpanzee genes is not a significant 
contributing factor to differences in gene expression between the two species, the 
proportion of genes associated with INDELs should be approximately equal for 
differentially expressed and non-differentially expressed genes.  This was not found to be 
the case in any of the tissues, and it was seen that the proportion of differentially 
expressed genes associated with INDELs was significantly greater (proportions test, 
p<0.05) than the proportion of non-differentially expressed genes associated with 
INDELs (Table 4.7).  
 
In order to test whether INDELs containing REs or NISs were a significant contributing 
factor to differences in gene expression between humans and chimpanzees, the proportion 
of differentially expressed genes associated with INDELs containing REs or NISs was 
compared with their non-differentially expressed counterparts. The proportion of 
differentially expressed genes associated with INDELs containing REs was significantly 
greater (proportions test, p<0.05) than their non-differentially expressed counterparts in 
all tissues (Table 4.8a), whereas the differentially expressed genes associated with 
INDELs containing NISs was significantly greater (proportions test, p<0.05) than their 
non-differentially expressed counterparts in all tissues, except kidney (Table 4.8b). While 
our results are consistent with the hypothesis that INDELs contribute significantly to 
differences in genes expression between humans and chimpanzees, this is not to say that 
other types of mutations are functionally insignificant. Indeed, there are a substantial 
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number of genes not associated with INDELs that are also significantly differentially 




Table 4.7: Association of INDEL variation with differential gene expression. All 
INDEL variation seen in each of the tissues was tested to see for association with 
differential gene expression between humans and chimpanzees. The proportion of 
differentially expressed genes (DE) associated with INDEL variation was significantly 
greater (proportions test, p<0.05) than the proportion of non-differentially expressed 
genes (Exp) associated with INDEL variation in all tissues. Proportions are given in 
parentheses. 
 
Tissue DE genes with 
INDELs / Total 
DE genes  




Test  (p-value) 
Brain  2266/6884 (0.33) 2153/7249(0.30) 4.054E-05 
Testis 3438/10803 (0.32) 1256/4642 (0.27) 3.93E-09 
Heart 2233/6843 (0.33) 1948/6654 (0.29) 2.7E-05 
Liver 1696/5308 (0.32) 2466/8376 (0.29) 0.0019 




Table 4.8: Association of differential gene expression with INDEL variation 
containing a) retrotransposon sequences (REs) and b) non-interspersed sequences 
(NISs). INDEL variation containing REs and NISs seen in each of the tissues was tested 
to see for association with differential gene expression between humans and 
chimpanzees. The proportion of differentially expressed genes associated with INDEL 
variation was significantly greater (proportions test, p<0.05) than the proportion of non-




Tissue DE genes with 
INDELS containing 
REs/ Total DE genes 
Exp genes with 
INDELs containing 




Brain 1916/6884 (0.28) 1790/7249 (0.25) 2.42E-05 
Testis 2862/10803 (0.26) 1072/4642 (0.23) 9.63E-06 
Heart 1876/6843 (0.27) 1636/6654 (0.25) 0.00019 
Liver 1416/5308 (0.26) 2072/8376 (0.25) 0.012 
Kidney 1843/6589 (0.28) 1776/7470 (0.24) 1.52E-08 
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Table 4.8 b)  
Tissue DE genes with 
INDELs containing 
NISs/ Total DE 
genes 
Exp genes with 
INDELs containing  




Brain 801/6884 (0.12) 762/7249 (0.1) 0.036 
Testis 1193/10803 (0.11) 440/4642 (0.094) 0.0041 
Heart 777/6843 (0.11) 658/6654 (0.098) 0.006 
Liver 590/5308 (0.11) 838/8376 (0.1) 0.041 





Over the ! 6 million years that the human and chimpanzee lineages have diverged from a 
common ancestor, the two species evolved a variety of distinctive morphological, 
behavioral, cognitive and other phenotypic traits (Varki and Altheide 2005). To explore 
the genetic basis of the phenotypic differences that distinguish humans from 
chimpanzees, a number of comparative genomic studies have been conducted in recent 
years (Li et al. 2001; Mikkelsen et al. 2005). Perhaps the most surprising finding coming 
out of these studies is the paucity of protein coding nucleotide variation existing between 
these two species, supporting earlier contentions that the basis of the phenotypic 
differences lies in the realm of gene regulation (King and Wilson 1975). 
Direct evidence in support of the regulatory hypothesis has recently been provided by a 
number of comparative microarray studies showing that significant differences in gene 
expression patterns exist between humans and chimpanzees, especially in organs (e.g., 
brain and testes) and functions (e.g., cognitive ability and fertility) directly related to 
some of the major phenotypic traits distinguishing the two species (Li et al. 2001; 
Khaitovich et al. 2005).  Questions remain, however, concerning the genetic basis of the 
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differences in gene regulation that separates humans from chimpanzees. One hypothesis 
is that the substantial INDEL variation that exists between humans and chimpanzees may 
contribute significantly to the regulatory differences between the species (Britten 2002; 
Polavarapu et al. 2006). To test this hypothesis, we categorized the INDEL variation 
existing between humans and chimpanzees that is located in or around genes and 
determined if this variation is significantly linked with species differences in gene 
expression.  Our results indicate that such an association does exist and that it is 
attributable to both interspersed (predominately retrotransposon) and non-interspersed 
associated INDEL variation. The majority of this INDEL variation is attributed to lineage 
specific insertions and predominantly to insertions within the human lineage (Table 4.2 
and Table 4.6). 
 
We found that relatively little of the human-chimpanzee INDEL variation maps to the 
upstream region of genes. Since many essential control sequences are known to map 
upstream of the transcriptional start site of eukaryotic genes (Levine and Tjian 2003), 
most of these cis-regulatory sequences likely evolved prior to the divergence of 
chimpanzees and humans from a common ancestor ! 6 million years ago. Thus, a 
possible explanation for the paucity of upstream INDEL variation between chimpanzees 
and humans in the upstream regions of genes is that most INDELs arising in this region 
are non-adaptive and thus rapidly removed by natural selection.   
 
We found that the majority of the INDEL variation between humans and chimpanzees 
that is significantly correlated with differences in gene expression maps to introns. While 
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some of the variation in gene expression associated with human intronic insertions may 
be due to the incorporation of these inserted sequences into mRNAs (affecting RNA 
stability, etc.), the majority are most likely exerting enhancer or other cis-regulatory 
effects. Several examples of such insert-mediated cis-regulatory mutations have been 
previously documented in mice, rats and humans (Rothenburg et al. 2002; Yamada et al. 
2006; Illarionova et al. 2007). 
 
Our finding is that most of the INDEL variation between humans and chimpanzees which 
is associated with differential gene expression is attributable to human insertions. This 
finding is interesting for two reasons. First, it is consistent with the view that much of the 
divergence in gene expression that exists between chimpanzees and humans may have 
been driven by accelerated regulatory evolution within the human lineage (Enard et al. 
2002; Gu and Gu 2003; Prabhakar et al. 2006; Wang et al. 2007).  Second, it suggests 
that at least with respect to the evolutionary contribution of INDELs to chimpanzee-
human divergence in gene expression, selection operating on de novo mutations may 
have been more important than selection operating on standing variation pre-existing in 
common ancestral populations. While previous analyses of gene expression and protein 
coding sequence variation between chimpanzees and humans revealed a pattern 
consistent with neutral evolution and negative selection (Khaitovich et al. 2005), our 
findings suggest that INDELs may have been a positive driving force behind human 





In this study we tested to see whether there is a significant association between INDEL 
variation and differential gene expression between humans and chimpanzees. Our results 
indicate that indeed such an association does exist, and this association is more 
predominant with INDELs present in the intronic region of the genes. INDELs containing 
both interspersed (predominantly) and non-interspersed sequences contribute to 
differential expression, and we conclude that differences between the two species may be 
due to insertions of these sequences in the human lineage. 
 
MATERIALS AND METHODS 
Initial datasets 
The database available at the UCSC Genome bioinformatics web site (Kent et al. 2002) 
was used to generate CGs and HGs datasets. These datasets contain genomic coordinates 
for CGs and HGs of sizes ranging from 80bp to 12,000bp. The CG dataset was generated 
by aligning the chimpanzee genome against the human genome build hg16 (July 2003) 
(Karolchik et al. 2003; Karolchik et al. 2004), and the HG dataset by aligning the human 
genome against the chimpanzee genome build panTro1 (Nov 2003). The CG and HG 
dataset coordinates were updated to the hg18 (Mar 2006) and panTro2 (Mar 2006) 
versions of the human and chimpanzee genome respectively, using genome browser 
utilities, Batch Coordinate Conversion liftOver tool (http://genome.ucsc.edu/util.html). 
Genomic sequences corresponding to the updated gap coordinates were downloaded from 
the UCSC genome database. Some of the gap sequences (76 CGs and 2581 HGs) not 
represented in the new versions of genome assemblies were removed in this process. 
 94 
Identification of INDELs 
Human genome (hg18), Chimpanzee genome (panTro2) and Macaque genome (rheMac2) 
sequences were downloaded from the UCSC genome database ftp website 
(ftp://hgdownload.cse.ucsc.edu/goldenPath). These genomes were aligned (see below), 
and in-house Perl scripts were used to process the alignment output files. 
 
CG (HG) coordinates were searched in the multiple (pair-wise and three-way) alignments 
against the human (chimpanzee) and macaque genomes using in-house Perl scripts. 
Characterization of a gap as a chimpanzee (human) deletion or human (chimpanzee) 
insertion was determined using macaque as out-group (Figure 4.1). 
 
(Note:  HGs and CGs characterized as partial deletions or partial insertions due to 
incomplete sequencing of the macaque (out-group) genome were removed from the 
analysis.) 
 
Characterization of sequences contained in INDELs 
The Repeat Masker program (http://www.repeatmasker.org) was used to identify all 
interspersed repeats in the INDEL sequences. These were further classified according to 
the type of interspersed repeats, i.e. SINE, LINE, ERV, SVA or DNA elements. INDEL 
sequences consisting of more than one type of interspersed repeats (e.g. ER inserted 
within a LINE element) were classified as Mosaic elements (ME). The tandem repeat 
finder program (Benson 1999) was used to identify tandem repeat sequences within the 
INDELs characterized as non-interspersed sequences (INDELs not containing 
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interspersed repeat sequences). The remainder of the non-interspersed sequences was 
classified as unique sequences. 
 
Association of human and chimpanzee genes with INDEL variation 
The genomic coordinates for the genic regions (transcription start, transcription end, 
coding sequence (CDS) start, CDS end, intron start, intron end, exon start and exon end) 
for the human and chimpanzee Ensembl genes were downloaded from the UCSC 
Genome Bioinformatics web site (Kent et al. 2002). For each gene, 5000 bps upstream 
region of the transcription start site and 5000 bps downstream of the transcription end site 
were included in the genic region to correct for the comparatively longer average length 
of introns (Hong et al. 2006). An INDEL was considered to be associated with the gene if 
the genomic coordinates of the INDEL overlapped with the coordinates of the genic 
region. In-house Perl scripts were used to match these coordinates. 
 
Analysis of microarray gene expression data  
The human-chimpanzee gene expression raw data from five different tissues (i.e. brain, 
heart, liver, kidney and testis) in 6 humans and 5 chimpanzees were obtained from a 
previous microarray (Affymetrix HGU1332plus arrays) study (Khaitovich et al. 2005). 
The expression data was analyzed using MAS 5.0 normalization method encoded in the 
Affymetrix function library of the Bioconductor package (www.bioconductor.org) 
developed for R statistical programming environment (www.rproject.org) Genes with 
significant differences in affy probe sequences between humans and chimpanzees and 
with inconsistent hybridization patterns within samples in a species were excluded from 
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the analysis. Probe-sets having at least one presence call in any of the samples, either 
from human or chimpanzee, were called as detected and used for further analysis. 
 
The expression values of these genes were normalized across samples by Z-score 
calculation using Spotfire Decision Site software (www.spotfire.com). Analysis of 
variance (ANOVA) was used to identify genes whose expression was significantly 
different (p<0.05) between human and chimpanzees in each of the tissues. 
 
Categories of genes associated with INDEL variation between humans and 
chimpanzees 
Genes associated with INDELs were grouped in two ways. First, they were grouped with 
respect to the type of sequences contained in the INDEL: a) interspersed repeat 
associated INDELs (>99% being retrotransposon sequences) or b) non–interspersed 
repeat associated INDELs. Second, genes associated with INDELs were grouped with 
respect to the location of the INDEL: intron, exon, upstream (within 5000bp upstream of 
transcription start site), or downstream (within 5000bp downstream of transcription 
termination site) genic locations. Some genes were grouped into more than one category 
(e.g., an INDEL in an upstream region that extends into the first intron). Genes located 
around INDELs comprised of retrotransposon sequences were further divided according 
to the type of retrotransposons (SINEs, LINEs, ERVs, SVAs or MEs). Genes associated 




Correlating INDEL variation with differential gene expression  
Differences in gene expression between chimpanzee and humans in each of the five 
tissues were partitioned for differentially expressed genes associated with INDELs vs. 
non-differentially expressed genes associated with INDELs. Proportions tests were used 
to determine the significance of the association of INDEL variation with differences in 
gene expression (p < 0.05) between the two species.  The association was confirmed with 
a chi-square test of independence. 
 
LIST OF ABBREVIATIONS: 
INDEL: insertion/ deletion; CIs: chimpanzee insertions; CDs: chimpanzee deletions; HIs: 
human insertions; HDs: human deletions; HGs: human gaps; CGs: chimpanzee gaps; 
REs: retrotransposon sequences; NISs: non-interspersed sequences; SINEs: short 
interspersed nuclear elements; LINEs: long interspersed nuclear elements; ERVs: 
endogenous retroviruses; SVAs: biologically active composite elements consisting of 
fragments of SINE, VNTRs-variable number of tandem repeats, and Alu elements; ME: 
Mosaic elements; CERV/PTERV: chimpanzee endogenous viruses; MYA: million years 
ago; CDS: coding sequences; hg: human genome; panTro: chimpanzee genome; 
rheMac2: macaque genome; ANOVA: Analysis of variance; DE: differentially expressed 




Human and chimpanzees differ in a number of phenotypic traits, chief among them are an 
increased size of the human brain (Carroll 2005; de Sousa and Wood 2007) and an 
increased propensity to cancer in humans (Seibold 1973). Apoptosis is known to play a 
role during neuronal development (Kuida et al. 1996; Honarpour et al. 2001; Joza et al. 
2001), as well as disease progression to cancer (Kerr et al. 1972). The research in this 
study looks at differences in apoptotic function between humans and chimpanzees, to 
understand the basis of these phenotypic differences. In addition, this study also 
addresses the genetic basis of the phenotypic differences between the two species by 
looking at the Insertion/Deletion (INDEL) sequence variation that exists between the two 
species. 
 
In this study, we saw that a number of genes were differentially expressed between 
humans and chimpanzees in five different tissues (brain, testis, heart, liver and kidney). 
To directly explore the consequences of the differences in gene expression, the gene 
expression differences between humans and chimpanzee brains were overlaid on known 
pathways. Results from the pathway analysis, suggested that the humans have a reduced 
apoptotic function in the brain, relative to chimpanzees. The reduced apoptotic function 
in the human brain, relative to chimpanzees, may have partly resulted in an increased size 
of the human brain.  
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The reduced apoptotic function in the human brain may have other consequences, besides 
it’s potential contribution to brain size. A reduction in apoptotic function may serve to 
enhance longevity in humans. In the brain, all the neurons are produced during the early 
developmental years (Oomen et al. 2009). Newer neurons are not formed later in life. For 
a very long-lived species like Homo sapiens (Finch 2010), a reduced apoptotic function 
may set the threshold for neurons relatively high compared to chimpanzees. This high 
threshold may ensure that humans don’t lose neurons that cannot be replaced later in life. 
 
When the gene expression analysis was extended to other tissues (e.g. testis, heart, liver 
and kidney), a similar trend of reduced apoptotic function in humans compared to 
chimpanzees was seen. These results suggested that the apoptotic function maybe 
generally reduced in humans. The reduced apoptotic function in humans may account for 
an increased propensity for cancer in humans compared to chimpanzees, as during cancer 
the apoptotic function is overall reduced (Hanahan and Weinberg 2000). The onset of 
cancer in humans typically takes place well after reproductive age 
(http://seer.cancer.gov/csr/1975_2005/). 
 
This antagonistic role of a reduced apoptotic function in humans during different life 
stages is analogous to a model of antagonistic pleiotropy, which was proposed by George 
C. Williams in 1957 to explain the evolutionary model of ageing (Williams 1957). 
According to this model, alleles that increase the fitness of an organism during early 
formative years are selected for, however the same alleles may have negative effects later 
in life. 
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Based on the above results, we hypothesized that the selection for increased cognitive 
ability in humans (by means of a reduced apoptotic function) may have had, as a side 
effect, an increased propensity for cancer in humans (Arora et al. 2009). There are two 
lines of evidence that support this hypothesis. First, chimpanzees have lower incidences 
of cancer relative to humans (McClure et al. 1973). In humans, death caused by a number 
of neoplasms is ~20%, compared to the incidences of these cancers in chimpanzees, 
which is ~2% (Seibold et al. 1973). Second, an increased apoptotic function associated 
with Huntington’s’ and Parkinson’s disease patients (Kiechle T et al. 2002) has been 
correlated with a decreased propensity for cancer in these patients (Eskenazi et al. 2007). 
  
In order to test the hypothesis of a reduced apoptotic function in humans, a series of 
apoptotic functional assays were conducted on primary fibroblast cell lines from humans, 
chimpanzees and macaques. Overall, human cells had higher cell viability, decreased 
caspase-3/7 activity and reduced ability to initiate apoptosis, compared to chimpanzees 
and macaques. These results are consistent with a reduced apoptotic function model in 
humans relative to chimpanzees and macaques and suggest that the reduction in apoptosis 
in humans is an evolutionary derived condition within the human lineage, subsequent to 
the divergence of humans and chimpanzees from a common ancestor 
 
An ideal way to further test the hypothesis of a reduced apoptotic function in humans 
would be to directly carry out tests on tissues obtained from human and chimpanzee 
samples. It would be even more interesting to compare samples obtained from human and 
chimpanzee cancer samples. However, accessibility to such tissue is extremely difficult, 
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given that there are low rates of cancer in chimpanzees and that chimpanzees are an 
endangered species.  
 
During brain development (Kiecker and Lumsden 2005) as well as cancer progression 
(Hanahan and Weinberg 2000), a number of pathways, other than apoptosis, are involved. 
By looking at pathways like Notch and Wnt signaling, it could be determined whether, 
just like apoptosis, these pathways show differences in their function between humans 
and chimpanzees. These differences in function could then be used to further confirm the 
basis of an increased brain size in humans, which is accompanied by an increased 
propensity for cancer in humans.  
 
To understand the genetic basis of the phenotypic differences between humans and 
chimpanzees, the INDEL variation between the two species was analyzed and correlated 
to differences in gene expression. Human and chimpanzees are ~98.5% identical at the 
nucleotide level (95% if INDEL variation is considered between the two species) 
(Mikkelsen et al. 2005). In spite of the similarity between the two species at the 
nucleotide level, there are a number of phenotypic differences between the two species. A 
number of studies have suggested that the genetic basis of the differences between 
humans and chimpanzees lies at the level of the INDEL variation, which may contribute 
to the regulatory evolution that exists between the two species (Britten 2002; Frazer et al. 
2003; Polavarapu et al. 2006).  
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In the INDEL analysis study, we saw a significant association of differential gene 
expression between the humans and chimpanzees with INDEL variation in various 
tissues. A majority of the INDEL variation was due to human-specific insertions and was 
mapped to the intronic region of the genes. Most of the INDELs were composed of either 
interspersed sequences (predominantly retrotransposons) or non-interspersed sequences, 
both of which are known to contribute to differences in gene regulation (McDonald 1993; 
Hammock and Young 2005; Mills et al. 2006a). These results are consistent with the 
findings that INDELs are significant contributors of variation between the two species 
(Volfovsky et al. 2009) and that INDELs composed of both interspersed (Britten 1997; 
Polavarapu et al. 2006) and non-interspersed sequences (Hammock and Young 2005) 
contribute to this variation.  
 
The INDEL analysis has systematically correlated INDEL variation with gene expression 
differences between humans and chimpanzees. This study can be used a model to 
understand the role that INDEL variation may play in causing differential expression 









SUPPLEMENTARY INFORMATION FOR CHAPTER 2 
 
Table A.1: Genes differentially expressed between human and chimpanzee brains 
associated, with the Huntington’s and Parkinson’s signaling pathways. The log ratio 
values of gene expression difference in human relative to chimpanzee are shown. A 
negative value indicates down-regulation in humans relative to chimpanzees while a 








AKT3 v-akt murine thymoma 
viral oncogene homolog 3 
(protein kinase B, gamma) 
chr1q43-q44 
 
Huntington’s  -0.34 
 
AP2A2 adaptor-related protein 
complex 2, alpha 2 subunit 
chr11p15.5 Huntington’s  0.37 
 




Huntington’s  0.22 
BDNF brain derived neurotrophic 
factor 
chr11p13 Huntington’s  -0.89 
BET1L blocked early in transport 1 
homolog (S. cerevisiae)-
like 
chr11p15.5 Huntington’s -1.18 
CACNA1B Calcium channel voltage- 
dependent, type L, alpha 
1B subunit 
chr9q34 Huntington’s 0.66 
CAPN2 calpain 2 chr1q41-q42 Huntington’s -0.63 
CAPN3 calpain 3 chr15q15.1-q21.1 Huntington’s  1.22 
CAPN5 calpain 5 chr11q14 Huntington’s -0.51 
CAPN 7 calpain 7 chr3p24 Huntington’s -0.39 
CASP2 caspase 2 chr7q34-q35 Huntington’s -1.44 
CASP6 caspase 6 chr4q25 Huntington’s -1.78 
CASP9 caspase 9 chr1p36.3-p36.1 Huntington’s/ 
Parkinson’s 
-0.35 
CLTC clathrin, heavy chain (Hc) chr16q22.1 Huntington’s  -0.21 
CPLX2 complexin 2 chr5q35.2 Huntington’s -1.26 
CREB1 cAMP responsive element 
binding protein 1 
chr2q34 Huntington’s  0.58 
CREBBP CREB binding protein chr16p13.3 Huntington’s -2.01 








Table A.1 continued 
DNAJB14 DnaJ (Hsp40) subfamily B 
member 14 
chr4q23 Huntington’s 0.55 
DNM1 Dynamin 1 chr9q34 
 
Huntington’s  0.43 
 
DYNC1I2 dynein, cytoplasmic 
1intermediate chain 2 
chr2q31.1 Huntington’s 0.52 
EGFR epidermal growth factor 
receptor 1  
chr7p12 
 
Huntington’s  0.87 
FRAP1 FK506 binding protein 12-
rapamycin associated 
protein 1 
chr1q36.2 Huntington’s -0.61 
GNAQ guanine nucleotide binding 




Huntington’s  0.67 
GNB1 guanine nucleotide binding 
protein (B protein), beta 
polypeptide 1 
chr1p36.33 Huntington’s  -0.38 
GNB4 guanine nucleotide binding 
protein (G protein), beta  
polypeptide 4 
chr3q26.2-q26.33 Huntington’s 0.84 
GNB2L1 guanine nucleotide binding 
protein (G protein), beta 
polypeptide 2- like 1 
chr5q35.3 Huntington’s 0.59 
GNG4 guanine nucleotide binding 
protein (G protein), gamma 
4 
chr1q42.3 Huntington’s 1.15 
GNG7 guanine nucleotide binding 




Huntington’s  0.98 
GNG12 guanine nucleotide binding 
protein (G protein),gamma 
12 
chr1p31.3 Huntington’s 1.94 
GOSR1 golgi SNAP receptor 
complex member 1 
chr17q11 Huntington’s  1.45 
GRB2 growth factor receptor-
bound protein 2 
chr17q24-q25 Huntington’s  -0.46 
GRIN2B glutamate receptor, 
ionotrophic , N-Methyl D-
aspartate 2B 
chr12p12 Huntington’s -1.91 
HDAC6 histone deacetylase 6 chrX11.23 Huntington’s  -0.52 
HDAC11 histone deacetylase 11         chr3p25.1       Huntington’s    
0.45 
HDAC2 histone deacetylase 2 chr6q21 Huntington’s  1.31 
HIP1 Huntington interacting 
protein 1  
chr7q11.23 Huntington’s -0.49 
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HSPA2 heat shock 70kDa protein 2 chr14q24.1 Huntington’s  1.91 
HSPA5 heat shock 70kDa protein 5 chr9q33-q34.1 Huntington’s 3.54 
HSPA9 heat shock 70kDa protein 9 chr5q31.1 Huntington’s 4.51 
IFT57 intraflagellar transport 57 
homolog 
chr3q13.12 Huntington’s -0.38 
ITPR1 inositol 1,4,5-triphosphate 
receptor type 1 
chr3p26-p25 Huntington’s 1.67 
JUN Jun oncogene chr1p32-p31 Huntington’s -0.46 
MAP2K7 Mitogen activated protein 
kinase kinase 7 
chr19p13.3-p13.2 Huntington’s  -0.47 
MAPK1 Mitogen activated protein 
kinase 1 
chr22q11.2|22q11.21 Huntington’s  -0.57 





MAPK8 Mitogen activated protein 
kinase 8 
chr10q11.2 Huntington’s -0.51 
MAPK9 Mitogen activated kinase 9 chr5q35 Huntington’s  1.03 
MAPK10 Mitogen activated kinase 
10 
chr4q22.1-q22.3 Huntington’s  -0.33 
NAPA N-ethylmaleimide-sensitive 
factor attachment protein, 
alpha 




factor attachment protein, 
gamma 
chr18p11.22 Huntington’s  1.32 
NCOR1 Nuclease receptor 
corepressor 1 
chr17p11.2 Huntington’s  -0.42 
NCOR2 Nuclease receptor 
corepressor 2 
chr12q24 Huntington’s  -0.44 
PIK3C3 phosphoinositide-3-kinase, 
class 3 
chr18q12.3 Huntington’s  1.82 
PIK3C2A phosphoinositide-3-kinase, 
class 3, catalytic alpha 
polypeptide 
chr11p15.5-p14 Huntington’s 1.19 
PIK3CA Phosphoinositide-3-kinase, 
catalytic, alpha polypeptide 
chr3q26.3 Huntington’s -0.74 
PIK3CB phosphoinositide-3-kinase, 
catalytic, beta polypeptide 
chr3q22.3 Huntington’s  0.55 
PIK3CD phosphoinositide-3-kinase, 
catalytic, delta polypeptide 
chr1p36.2 Huntington’s  0.72 
PIK3R1 phosphoinositide-3-kinase, 
regulatory subunit 1 (p85 
alpha) 
chr5q13.1 Huntington’s  -1.10 
PLCB1 phospholipase C, beta 1 
(phosphoinositide-specific) 
chr20p12 Huntington’s  -1.88 
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PLCB4 phospholipase C, beta 4 chr20p12 Huntington’s  -0.75 
POLR2A polymerase (RNA) II 
(DNA directed) 
polypeptide A, 220kDa 
chr17p13.1 Huntington’s  0.55 
POLR2G polymerase (RNA) II 
(DNA directed) 
polypeptide G 
chr11q13.1 Huntington’s  0.34 
POLR2H polymerase (RNA) II 
(DNA directed) 
polypeptide H 
chr3q28 Huntington’s -0.21 
POLR2I polymerase (RNA) II 
(DNA directed) 
polypeptide I, 14.5kDa 
chr19q12 Huntington’s  0.94 
POLR2J polymerase (RNA) II 
(DNA directed) 
polypeptide J, 13.3kDa 
chr7q22.1 Huntington’s 1.4 
POLR2K polymerase (RNA) II 
(DNA directed) 
polypeptide K, 7.0kDa 
chr8q22.2 Huntington’s 1.04 
PRKCE protein kinase C, epsilon chr2p21 Huntington’s  -0.74 
PRKCI protein kinase C, iota  chr3q26.3 Huntington’s  1.2 
PRKCQ protein kinase C, theta chr10p15 Huntington’s 0.55 
RASA1 RAS p21 protein activator 
(GTPase activating protein) 
1 
chr5q13.3 Huntington’s  0.25 
RCOR1 REST corepressor 1 chr14q32.32 Huntington’s  -0.30 
SDHB succinate dehydrogenase 
complex, subunit B, iron 
sulfur (Ip) 
chr1p36.1-p35 Huntington’s -1.43 
SH3GL3 SH3-domain GRB2-like 3 chr15q24 Huntington’s  0.48 
SHC1 SHC (Src homology 2 
domain containing) 
transforming protein 1 
chr1q21 Huntington’s -0.21 
SNAP25 synaptosomal-associated 
protein, 25kDa 
chr20p12-p11.2 Huntington’s  -0.31 
TAF4 TAF4 RNA polymerase II, 
TATA box binding protein 
(TBP)-associated factor, 
135kDa 
chr20q13.33 Huntington’s -1.14 
TAF9B TAF9B RNA polymerase 
II, TATA box binding 
protein (TBP)-associated 
factor, 31kDa 
chrXq13.1-q21.1 Huntington’s -0.75 
TBP TATA box binding protein chr6q27 Huntington’s  -0.39 
UBB ubiquitin B chr17p12-11.2 Huntington’s  0.27 
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UBC ubiquitin C chr12q24.3 Huntington’s  -0.31 
ZDHHC17 Zinc finger, DHCC-type 
containing 17 
chr12q21.2 Huntington’s  -0.41 












SEPT5 septin 5 chr22q11.21 Parkinson’s 0.43 
SNCA synuclein, alpha chr4q21 Huntington’s 
/Parkinson’s  
1.47 
UCHL1 Ubiquitin carboxyl 
terminal esterase L1 




Genetic basis of the observed differences in expression of apoptotic genes between 
humans and chimpanzees  
In a preliminary effort to discern the genetic basis of the observed differences in the 
expression of apoptotic genes, a comparative sequence alignment was performed between 
the 37 apoptotic genes differentially expressed between human and chimpanzee using the 
macaque as an out-group. Remarkably, none of the 37 differentially expressed genes 
displayed variation within their coding regions. In contrast, significant Insertion/Deletion 
(INDEL) variation was detected between the two species in introns and upstream regions 
at 34 of the 37 genes examined (Table A.2, Figure A.1) as analyzed on the UCSC 
genome browser (Kent et al. 2002). A number of these genes with INDEL variation, e.g., 
CYCS, AIFM1, DIABLO, CASP6, CASP9, BID, BIRC4 and HTRA2, are involved in 
the intrinsic apoptotic pathway, and a majority of these have this INDEL variation in the 
upstream region. Two of these genes, e.g. DIABLO and HTRA2, have transcription 
factor binding sites (TFBS) missing in the chimpanzee sequences. 
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Table A.2: Apoptotic pathway genes differentially expressed between the human 
and chimpanzee brains are associated with INDEL variation.  
No nucleotide or INDEL variation was detected within the coding regions (exons) of the 
37 apoptotic pathway genes differentially expressed between the human and chimpanzee 
brain. In contrast, substantial INDEL variation was detected in introns and/or upstream 
regions (1-5000 bp 5’ to the transcriptional start site) in 34 of the 37 genes. Pair wise 
alignments of mRNA sequences (Needleman and Wunsch 1970) were used to search for 
nucleotide variation. INDEL variation was identified using the macaque as an out-group. 
(H = human, C = chimpanzee, " = Insertion, # = Deletion, * indicates possible 
underestimate of INDEL variation in upstream region due to poor sequence quality). Size 
of INDEL and distinguishing feature is given in parentheses: TFBS= Transcription factor 
binding sites; SINE = short interspersed nuclear element; LINE = long interspersed 
nuclear element; SVA= composite of SINE, Variable number tandem repeat and Alu; 
LTR = long terminal repeat retrotransposon element; CpG= Cytosine phosphate guanine 
region. 
 
INDEL VARIATION Gene Symbol 
INTRON 
UPSTREAM REGION 
1.AIFM1* None 1 C #(3328 bps long)  
2.BID* 1 H # (184 bps; 
tandem repeat)  
None 
3.BIRC4* 1 C # (330 bps; 
SINE element) 
1 C # (1240 bps; 3 SINE 
elements) 
4.CAPN2 None 1 H # (10 bps; part of SINE 
element) 
5.CAPN3 None 1 C # (401 bps; 2 SINE elements) 
6.CAPN5 1 H " (2337 bps; 
Other repeat)  
None 
7.CAPN7 1 C " (82 bps; 
simple repeat) 
None 
8.CASP2 1 C # (21 bps; part 
of LTR element) 
None 
9.CASP6 None 1 C # (1630 bps; 3 SINE 
elements) 
10.CASP9 None 1 C # (10 bps; part of SINE 
element) 
11.CHUK None None 
12. CYCS None 1 H# (4711 bps; 4 SINE 
elements) 
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Table A.2 continued 
13. DDR1 None 1 H#(23 bps; part of LINE 
element) 
14.DDR2 2 H " (135 bps; 
simple repeat and 
2209 bps; LINE 
element) 
None 
15.DFFA None None 
16.DIABLO* None 1 C # (840 bps; part CpG region 
along with 3 TFBS missing) 
17.EGFR 1 C " (313 bps; 
SINE element) 
None 
18.FGFR2 1 H " (295 bps; 
SINE element) 
1 H " (92 bps; SINE element) 
19.HTRA2* None 1 C # (854 bps; part CpG region 
along with 4 TFBS missing) 
20.IKBKB 1 H #  (313 bps; 
SINE element) 
None 
21.KRAS 1 C # (216 bps; 
part  SINE 
element missing) 
None 
22. MAP2K2 1 H " (90 bps; 
simple repeat) 
1 C # (339 bps; part CpG region 
along with 1 TFBS missing) 
23.MAP2K7* None 3 C # (311 and 123 bps; 2 SINE 
elements and 932 bps; part of 
CpG region along with 2 TFBS 
missing) 
24.MAP3K5 1 C "(134 bps; 
simple repeat) 
1 H # (295 bps; 1 SINE element) 
25.MAP4K4 2 H "(315 bps; 1 
SINE element and 
144 bps; simple 
repeat) 
None 
26.MAPK1 1 H "(94 bps; part 
of SINE element) 
1 H # (171 bps; part of a SINE 
element) 
27.MAPK3 None 1 H # (1959 bps; 5 SINE 
elements) 
28.MAPK8 None 1 C #(36bps) 
29.MRAS None 1 C # (28 bps; part of a SINE 
element) 




Table A.2 continued 
31.PDGFRA 1 H # (1889 bps; 
SVA element) 
None 
1 H #(112 bps; 
Simple repeat) 
32. PRKCE 
5 H " (314 bps, 
318 bps, 314 bps, 
317 bps and 308 
bps; 5 SINE 
elements) 
None 
33.RAF1 None 1 H #(26 bps; part of SINE 
element) 
34.RELA None 1 C # (47 bps; part of SINE 
element) 




36.TEK None None 
37.TYRO3 None 2 C # (1444 bps, 776 bps; part of 










Figure A.1: An example of INDEL variation located upstream of an apoptotic 
pathway gene e.g. cytochrome C (CYCS).  
All alignments between human, chimpanzee and macaque (out-group) sequences were 
performed employing the Genome Browser Gateway [(Kent et al. 2002),Human, 
Chimpanzee and Macaque 2006 Assembly] and using the Needleman-Wunsch global 
alignment algorithm (Needleman and Wunsch 1970). A 4.7 kb region containing four 
SINE elements has been deleted from a region upstream of the human cytochrome C 
(CYCS) gene since the divergence of humans and chimpanzees from a common ancestor. 
Significant differences in CYCS expression were detected in human and chimpanzee 
brains despite the fact that no nucleotide differences exist between the two species within 










SUPPLEMENTARY INFORMATION FOR CHAPTER 4 
Table B.1: Number of genes associated with INDELs and non-INDELs. The numbers 
in the four right-most columns are the number of genes differentially expressed (DE) or 
not (Exp) in each tissue that are associated with INDELs and non-INDELs 
 
  INDELs  non-INDELs 
Tissue (Total number of 
genes detected in each 
tissue) 
Number of 
DE genes  
Number of 
Exp genes  
Number of 
DE genes  
Number of 
Exp genes  
Brain (14133) 2266 2153 4618 5096 
Testis (15445) 3438  1256 7365 3386 
Heart (13497) 2233  1948 4610 4706 
Liver (13684) 1696 2466 3612 5910 
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